Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Matcheri S Keshavan, M.D.

TitleStanley Cobb Professor of Psychiatry
InstitutionBeth Israel Deaconess Medical Center
DepartmentPsychiatry
AddressBIDMC-Mass. Mental Health Center
75 Fenwood Rd
Boston MA 02115
Phone617/754-1256

 Mentoring 
 current student opportunities
Available: 09/15/12, Expires: 09/14/14

We are investigating alterations in brain structure and function in major psychiatric disorders such as schizophrenia and bipolar disorders. Our goal is to understand the pathophysiology of these disorders as well as approaches to better diagnosis and treatment response prediction. The student will learn how to process brain images for structure (MRI), function (fMRI) and neurochemistry (MRS). Opportunities are also available for the student to be involved in supervised clinical assessments and novel treatment initiatives.


 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Romo-Nava F, Hoogenboom WS, Pelavin PE, Alvarado JL, Bobrow LH, Macmaster FP, Keshavan M, McCarley RW, Shenton ME. Pituitary volume in schizophrenia spectrum disorders. Schizophr Res. 2013 May; 146(1-3):301-7.
    View in: PubMed
  2. Keshavan MS, Clementz BA, Pearlson GD, Sweeney JA, Tamminga CA. Reimagining psychoses: An agnostic approach to diagnosis. Schizophr Res. 2013 May; 146(1-3):10-6.
    View in: PubMed
  3. Keshavan MS. DSM-5 and incremental progress in psychiatric nosology. Asian J Psychiatr. 2013 Apr; 6(2):97-8.
    View in: PubMed
  4. Keshavan MS. How to write a grant and get it funded. Asian J Psychiatr. 2013 Feb; 6(1):78-9.
    View in: PubMed
  5. Keshavan MS, Shah JL. Violence and mental illness. Asian J Psychiatr. 2013 Feb; 6(1):1-2.
    View in: PubMed
  6. Keshavan MS, Kaneko Y. Secondary psychoses: an update. World Psychiatry. 2013 Feb; 12(1):4-15.
    View in: PubMed
  7. Caplan B, Zimmet SV, Meyer EC, Friedman-Yakoobian M, Monteleone T, Jude Leung Y, Guyer ME, Rood LL, Keshavan MS, Seidman LJ. Prevention and Recovery in Early Psychosis (PREP(®)): Building a public-academic partnership program in Massachusetts, United States. Asian J Psychiatr. 2013 Apr; 6(2):171-7.
    View in: PubMed
  8. Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rössler A, Schultze-Lutter F, Keshavan M, Wood S, Ruhrmann S, Seidman LJ, Valmaggia L, Cannon T, Velthorst E, De Haan L, Cornblatt B, Bonoldi I, Birchwood M, McGlashan T, Carpenter W, McGorry P, Klosterkötter J, McGuire P, Yung A. The Psychosis High-Risk State: A Comprehensive State-of-the-Art Review. JAMA Psychiatry. 2013 Jan; 70(1):107-20.
    View in: PubMed
  9. Kaneko Y, Keshavan M. Cognitive remediation in schizophrenia. Clin Psychopharmacol Neurosci. 2012 Dec; 10(3):125-35.
    View in: PubMed
  10. Wojtalik JA, Eack SM, Pollock BG, Keshavan MS. Prefrontal gray matter morphology mediates the association between serum anticholinergicity and cognitive functioning in early course schizophrenia. Psychiatry Res. 2012 Nov 30; 204(2-3):61-7.
    View in: PubMed
  11. Yung AR, Woods SW, Ruhrmann S, Addington J, Schultze-Lutter F, Cornblatt BA, Amminger GP, Bechdolf A, Birchwood M, Borgwardt S, Cannon TD, de Haan L, French P, Fusar-Poli P, Keshavan M, Klosterkötter J, Kwon JS, McGorry PD, McGuire P, Mizuno M, Morrison AP, Riecher-Rössler A, Salokangas RK, Seidman LJ, Suzuki M, Valmaggia L, van der Gaag M, Wood SJ, McGlashan TH. Whither the attenuated psychosis syndrome? Schizophr Bull. 2012 Nov; 38(6):1130-4.
    View in: PubMed
  12. Frazier TW, Keshavan MS, Minshew NJ, Hardan AY. A two-year longitudinal MRI study of the corpus callosum in autism. J Autism Dev Disord. 2012 Nov; 42(11):2312-22.
    View in: PubMed
  13. Ivleva EI, Bidesi AS, Thomas BP, Meda SA, Francis A, Moates AF, Witte B, Keshavan MS, Tamminga CA. Brain gray matter phenotypes across the psychosis dimension. Psychiatry Res. 2012 Oct 30; 204(1):13-24.
    View in: PubMed
  14. Keshavan MS. Spirituality and positive mental health. Asian J Psychiatr. 2012 Dec; 5(4):289.
    View in: PubMed
  15. Wojtalik JA, Eack SM, Keshavan MS. Structural neurobiological correlates of Mayer-Salovery-Caruso Emotional Intelligence Test performance in early course schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jan 10; 40:207-12.
    View in: PubMed
  16. Salzman C, Seidman LJ, Keshavan MS. The Massachusetts Mental Health Center: going forward after 100 years. Am J Psychiatry. 2012 Oct; 169(10):1037.
    View in: PubMed
  17. Shah J, Eack SM, Montrose DM, Tandon N, Miewald JM, Prasad KM, Keshavan MS. Multivariate prediction of emerging psychosis in adolescents at high risk for schizophrenia. Schizophr Res. 2012 Nov; 141(2-3):189-96.
    View in: PubMed
  18. Brady RO, Cooper A, Jensen JE, Tandon N, Cohen B, Renshaw P, Keshavan M, Öngür D. A longitudinal pilot proton MRS investigation of the manic and euthymic states of bipolar disorder. Transl Psychiatry. 2012; 2:e160.
    View in: PubMed
  19. Stolz E, Pancholi KM, Goradia DD, Paul S, Keshavan MS, Nimgaonkar VL, Prasad KM. Brain activation patterns during visual episodic memory processing among first-degree relatives of schizophrenia subjects. Neuroimage. 2012 Nov 15; 63(3):1154-61.
    View in: PubMed
  20. Francis AN, Bhojraj TS, Prasad KM, Montrose D, Eack SM, Rajarethinam R, van Elst LT, Keshavan MS. Alterations in the cerebral white matter of genetic high risk offspring of patients with schizophrenia spectrum disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jan 10; 40:187-92.
    View in: PubMed
  21. Yao JK, Condray R, Dougherty GG, Keshavan MS, Montrose DM, Matson WR, McEvoy J, Kaddurah-Daouk R, Reddy RD. Associations between purine metabolites and clinical symptoms in schizophrenia. PLoS One. 2012; 7(8):e42165.
    View in: PubMed
  22. Francis AN, Seidman LJ, Jabbar GA, Mesholam-Gately R, Thermenos HW, Juelich R, Proal AC, Shenton M, Kubicki M, Mathew I, Keshavan M, Delisi LE. Alterations in brain structures underlying language function in young adults at high familial risk for schizophrenia. Schizophr Res. 2012 Oct; 141(1):65-71.
    View in: PubMed
  23. Srihari VH, Shah J, Keshavan MS. Is early intervention for psychosis feasible and effective? Psychiatr Clin North Am. 2012 Sep; 35(3):613-31.
    View in: PubMed
  24. Shashi V, Francis A, Hooper SR, Kranz PG, Zapadka M, Schoch K, Ip E, Tandon N, Howard TD, Keshavan MS. Increased corpus callosum volume in children with chromosome 22q11.2 deletion syndrome is associated with neurocognitive deficits and genetic polymorphisms. Eur J Hum Genet. 2012 Oct; 20(10):1051-7.
    View in: PubMed
  25. Keshavan MS, Sanghavi K. Psychiatric genetics research in Asia. Asian J Psychiatr. 2012 Jun; 5(2):123-4.
    View in: PubMed
  26. Shashi V, Veerapandiyan A, Keshavan MS, Zapadka M, Schoch K, Kwapil TR, Hooper SR, Stanley JA. Altered development of the dorsolateral prefrontal cortex in chromosome 22q11.2 deletion syndrome: an in vivo proton spectroscopy study. Biol Psychiatry. 2012 Oct 15; 72(8):684-91.
    View in: PubMed
  27. Ethridge LE, Hamm JP, Shapiro JR, Summerfelt AT, Keedy SK, Stevens MC, Pearlson G, Tamminga CA, Boutros NN, Sweeney JA, Keshavan MS, Thaker G, Clementz BA. Neural activations during auditory oddball processing discriminating schizophrenia and psychotic bipolar disorder. Biol Psychiatry. 2012 Nov 1; 72(9):766-74.
    View in: PubMed
  28. Das Chakraborty R, Chakraborty D, Bernal AJ, Schoch K, Howard TD, Ip EH, Hooper SR, Keshavan MS, Jirtle RL, Shashi V. Dysregulation of DGCR6 and DGCR6L: psychopathological outcomes in chromosome 22q11.2 deletion syndrome. Transl Psychiatry. 2012; 2:e105.
    View in: PubMed
  29. Kaddurah-Daouk R, McEvoy J, Baillie R, Zhu H, K Yao J, Nimgaonkar VL, Buckley PF, Keshavan MS, Georgiades A, Nasrallah HA. Impaired plasmalogens in patients with schizophrenia. Psychiatry Res. 2012 Aug 15; 198(3):347-52.
    View in: PubMed
  30. Shad MU, Keshavan MS, Steinberg JL, Mihalakos P, Thomas BP, Motes MA, Soares JC, Tamminga CA. Neurobiology of self-awareness in schizophrenia: an fMRI study. Schizophr Res. 2012 Jul; 138(2-3):113-9.
    View in: PubMed
  31. Meda SA, Gill A, Stevens MC, Lorenzoni RP, Glahn DC, Calhoun VD, Sweeney JA, Tamminga CA, Keshavan MS, Thaker G, Pearlson GD. Differences in resting-state functional magnetic resonance imaging functional network connectivity between schizophrenia and psychotic bipolar probands and their unaffected first-degree relatives. Biol Psychiatry. 2012 May 15; 71(10):881-9.
    View in: PubMed
  32. Diwadkar VA, Wadehra S, Pruitt P, Keshavan MS, Rajan U, Zajac-Benitez C, Eickhoff SB. Disordered corticolimbic interactions during affective processing in children and adolescents at risk for schizophrenia revealed by functional magnetic resonance imaging and dynamic causal modeling. Arch Gen Psychiatry. 2012 Mar; 69(3):231-42.
    View in: PubMed
  33. Murthy NV, Mahncke H, Wexler BE, Maruff P, Inamdar A, Zucchetto M, Lund J, Shabbir S, Shergill S, Keshavan M, Kapur S, Laruelle M, Alexander R. Computerized cognitive remediation training for schizophrenia: an open label, multi-site, multinational methodology study. Schizophr Res. 2012 Aug; 139(1-3):87-91.
    View in: PubMed
  34. Hamm JP, Ethridge LE, Shapiro JR, Stevens MC, Boutros NN, Summerfelt AT, Keshavan MS, Sweeney JA, Pearlson G, Tamminga CA, Thaker G, Clementz BA. Spatiotemporal and frequency domain analysis of auditory paired stimuli processing in schizophrenia and bipolar disorder with psychosis. Psychophysiology. 2012 Apr; 49(4):522-30.
    View in: PubMed
  35. Nasrallah H, Tandon R, Keshavan M. Beyond the facts in schizophrenia: closing the gaps in diagnosis, pathophysiology, and treatment. Epidemiol Psychiatr Sci. 2011 Dec; 20(4):317-27.
    View in: PubMed
  36. Shad MU, Brent BK, Keshavan MS. Neurobiology of self-awareness deficits in schizophrenia: A hypothetical model. Asian J Psychiatr. 2011 Dec; 4(4):248-54.
    View in: PubMed
  37. Balodhi JP, Keshavan MS. Bhagavadgita and psychotherapy. Asian J Psychiatr. 2011 Dec; 4(4):300-2.
    View in: PubMed
  38. Tandon N, Montrose D, Shah J, Rajarethinam RP, Diwadkar VA, Keshavan MS. Early prodromal symptoms can predict future psychosis in familial high-risk youth. J Psychiatr Res. 2012 Jan; 46(1):105-10.
    View in: PubMed
  39. Diwadkar VA, Pruitt P, Zhang A, Radwan J, Keshavan MS, Murphy E, Rajan U, Zajac-Benitez C. The neural correlates of performance in adolescents at risk for schizophrenia: inefficiently increased cortico-striatal responses measured with fMRI. J Psychiatr Res. 2012 Jan; 46(1):12-21.
    View in: PubMed
  40. Keshavan MS, Morris DW, Sweeney JA, Pearlson G, Thaker G, Seidman LJ, Eack SM, Tamminga C. A dimensional approach to the psychosis spectrum between bipolar disorder and schizophrenia: the Schizo-Bipolar Scale. Schizophr Res. 2011 Dec; 133(1-3):250-4.
    View in: PubMed
  41. Lewandowski KE, Cohen BM, Keshavan MS, Ongür D. Relationship of neurocognitive deficits to diagnosis and symptoms across affective and non-affective psychoses. Schizophr Res. 2011 Dec; 133(1-3):212-7.
    View in: PubMed
  42. Li H, Eack SM, Montrose DM, Miewald JM, Keshavan M. Longitudinal treatment outcome of African American and Caucasian patients with first episode psychosis. Asian J Psychiatr. 2011 Dec; 4(4):266-71.
    View in: PubMed
  43. Mehta UM, Thirthalli J, Gangadhar BN, Keshavan MS. Need for culture specific tools to assess social cognition in schizophrenia. Schizophr Res. 2011 Dec; 133(1-3):255-6.
    View in: PubMed
  44. Keshavan MS. The tale of Rauwolfia Serpentina and the contributions of Asian Psychiatry. Asian J Psychiatr. 2011 Sep; 4(3):214-5.
    View in: PubMed
  45. Keshavan MS. The changing global mental health landscape and need for leadership. Asian J Psychiatr. 2011 Sep; 4(3):161.
    View in: PubMed
  46. Shashi V, Veerapandiyan A, Schoch K, Kwapil T, Keshavan M, Ip E, Hooper S. Social skills and associated psychopathology in children with chromosome 22q11.2 deletion syndrome: implications for interventions. J Intellect Disabil Res. 2012 Sep; 56(9):865-78.
    View in: PubMed
  47. Rajarethinam R, Venkatesh BK, Peethala R, Phan KL, Keshavan M. Reduced activation of superior temporal gyrus during auditory comprehension in young offspring of patients with schizophrenia. Schizophr Res. 2011 Aug; 130(1-3):101-5.
    View in: PubMed
  48. Mehta UM, Thirthalli J, Naveen Kumar C, Mahadevaiah M, Rao K, Subbakrishna DK, Gangadhar BN, Keshavan MS. Validation of Social Cognition Rating Tools in Indian Setting (SOCRATIS): A new test-battery to assess social cognition. Asian J Psychiatr. 2011 Sep; 4(3):203-9.
    View in: PubMed
  49. Keshavan MS. How you can get your psychiatry scientific paper accepted. Asian J Psychiatr. 2011 Sep; 4(3):216-7.
    View in: PubMed
  50. Keshavan MS, Montrose DM, Miewald JM, Jindal RD. Sleep correlates of cognition in early course psychotic disorders. Schizophr Res. 2011 Sep; 131(1-3):231-4.
    View in: PubMed
  51. Diwadkar VA, Pruitt P, Goradia D, Murphy E, Bakshi N, Keshavan MS, Rajan U, Reid A, Zajac-Benitez C. Fronto-parietal hypo-activation during working memory independent of structural abnormalities: conjoint fMRI and sMRI analyses in adolescent offspring of schizophrenia patients. Neuroimage. 2011 Sep 1; 58(1):234-41.
    View in: PubMed
  52. Keshavan MS, Eack SM, Wojtalik JA, Prasad KM, Francis AN, Bhojraj TS, Greenwald DP, Hogarty SS. A broad cortical reserve accelerates response to cognitive enhancement therapy in early course schizophrenia. Schizophr Res. 2011 Aug; 130(1-3):123-9.
    View in: PubMed
  53. Prasad KM, Eack SM, Goradia D, Pancholi KM, Keshavan MS, Yolken RH, Nimgaonkar VL. Progressive gray matter loss and changes in cognitive functioning associated with exposure to herpes simplex virus 1 in schizophrenia: a longitudinal study. Am J Psychiatry. 2011 Aug; 168(8):822-30.
    View in: PubMed
  54. Diwadkar VA, Goradia D, Hosanagar A, Mermon D, Montrose DM, Birmaher B, Axelson D, Rajarathinem R, Haddad L, Amirsadri A, Zajac-Benitez C, Rajan U, Keshavan MS. Working memory and attention deficits in adolescent offspring of schizophrenia or bipolar patients: comparing vulnerability markers. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jul 1; 35(5):1349-54.
    View in: PubMed
  55. Yao JK, Keshavan MS. Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view. Antioxid Redox Signal. 2011 Oct 1; 15(7):2011-35.
    View in: PubMed
  56. Diwadkar VA, Segel J, Pruitt P, Murphy ER, Keshavan MS, Radwan J, Rajan U, Zajac-Benitez C. Hypo-activation in the executive core of the sustained attention network in adolescent offspring of schizophrenia patients mediated by premorbid functional deficits. Psychiatry Res. 2011 May 31; 192(2):91-9.
    View in: PubMed
  57. Brent BK, Giuliano AJ, Zimmet SV, Keshavan MS, Seidman LJ. Insight into illness in patients and caregivers during early psychosis: a pilot study. Schizophr Res. 2011 Apr; 127(1-3):100-6.
    View in: PubMed
  58. Tandon R, Nasrallah HA, Keshavan MS. "Just the facts": meandering in schizophrenia's many forests. Schizophr Res. 2011 May; 128(1-3):5-6.
    View in: PubMed
  59. Li H, Keshavan M. Risk factors of suicide: Need for more research in Asian populations. Asian J Psychiatr. 2011 Mar; 4(1):1.
    View in: PubMed
  60. Keshavan MS, Nasrallah HA, Tandon R. Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse. Schizophr Res. 2011 Apr; 127(1-3):3-13.
    View in: PubMed
  61. Bakshi N, Pruitt P, Radwan J, Keshavan MS, Rajan U, Zajac-Benitez C, Diwadkar VA. Inefficiently increased anterior cingulate modulation of cortical systems during working memory in young offspring of schizophrenia patients. J Psychiatr Res. 2011 Aug; 45(8):1067-76.
    View in: PubMed
  62. Keshavan MS, Brady R. Biomarkers in schizophrenia: we need to rebuild the Titanic. World Psychiatry. 2011 Feb; 10(1):35-6.
    View in: PubMed
  63. Condray R, Dougherty GG, Keshavan MS, Reddy RD, Haas GL, Montrose DM, Matson WR, McEvoy J, Kaddurah-Daouk R, Yao JK. 3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia. Int J Neuropsychopharmacol. 2011 Jul; 14(6):756-67.
    View in: PubMed
  64. Reddy R, Fleet-Michaliszyn S, Condray R, Yao JK, Keshavan MS, Reddy R. Reduction in perseverative errors with adjunctive ethyl-eicosapentaenoic acid in patients with schizophrenia: Preliminary study. Prostaglandins Leukot Essent Fatty Acids. 2011 Mar-Apr; 84(3-4):79-83.
    View in: PubMed
  65. Jou RJ, Mateljevic N, Minshew NJ, Keshavan MS, Hardan AY. Reduced central white matter volume in autism: implications for long-range connectivity. Psychiatry Clin Neurosci. 2011 Feb; 65(1):98-101.
    View in: PubMed
  66. Lewandowski KE, Eack SM, Hogarty SS, Greenwald DP, Keshavan MS. Is cognitive enhancement therapy equally effective for patients with schizophrenia and schizoaffective disorder? Schizophr Res. 2011 Feb; 125(2-3):291-4.
    View in: PubMed
  67. Francis AN, Bhojraj TS, Prasad KM, Kulkarni S, Montrose DM, Eack SM, Keshavan MS. Abnormalities of the corpus callosum in non-psychotic high-risk offspring of schizophrenia patients. Psychiatry Res. 2011 Jan 30; 191(1):9-15.
    View in: PubMed
  68. Li H, Keshavan M. Mental health of Asian American populations: Challenges and opportunities. Asian J Psychiatr. 2010 Dec; 3(4):161-2.
    View in: PubMed
  69. Javed A, Keshavan M. Obituary. Asian J Psychiatr. 2010 Dec; 3(4):252-3.
    View in: PubMed
  70. Salzman C, Glick I, Keshavan MS. The 7 sins of psychopharmacology. J Clin Psychopharmacol. 2010 Dec; 30(6):653-5.
    View in: PubMed
  71. Keshavan MS. Schizophrenia: the final frontier. Festschrift for robin m. Murray. Asian J Psychiatr. 2010 Dec; 3(4):250-1.
    View in: PubMed
  72. Keshavan MS, DeLisi LE, Seidman LJ. Early and broadly defined psychosis risk mental states. Schizophr Res. 2011 Mar; 126(1-3):1-10.
    View in: PubMed
  73. Eack SM, Pogue-Geile MF, Greenwald DP, Hogarty SS, Keshavan MS. Mechanisms of functional improvement in a 2-year trial of cognitive enhancement therapy for early schizophrenia. Psychol Med. 2011 Jun; 41(6):1253-61.
    View in: PubMed
  74. Jou RJ, Minshew NJ, Keshavan MS, Vitale MP, Hardan AY. Enlarged right superior temporal gyrus in children and adolescents with autism. Brain Res. 2010 Nov 11; 1360:205-12.
    View in: PubMed
  75. Barbour T, Murphy E, Pruitt P, Eickhoff SB, Keshavan MS, Rajan U, Zajac-Benitez C, Diwadkar VA. Reduced intra-amygdala activity to positively valenced faces in adolescent schizophrenia offspring. Schizophr Res. 2010 Nov; 123(2-3):126-36.
    View in: PubMed
  76. Venkatasubramanian G, Jayakumar PN, Keshavan MS, Gangadhar BN. Schneiderian first rank symptoms and inferior parietal lobule cortical thickness in antipsychotic-naïve schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jan 15; 35(1):40-6.
    View in: PubMed
  77. Shashi V, Keshavan M, Kaczorowski J, Schoch K, Lewandowski KE, McConkie-Rosell A, Hooper SR, Kwapil TR. Socioeconomic status and psychological function in children with chromosome 22q11.2 deletion syndrome: implications for genetic counseling. J Genet Couns. 2010 Oct; 19(5):535-44.
    View in: PubMed
  78. Tandon R, Nasrallah HA, Keshavan MS. Schizophrenia, "just the facts" 5. Treatment and prevention. Past, present, and future. Schizophr Res. 2010 Sep; 122(1-3):1-23.
    View in: PubMed
  79. Bhojraj TS, Sweeney JA, Prasad KM, Eack S, Rajarethinam R, Francis AN, Montrose DM, Keshavan MS. Progressive alterations of the auditory association areas in young non-psychotic offspring of schizophrenia patients. J Psychiatr Res. 2011 Feb; 45(2):205-12.
    View in: PubMed
  80. Shashi V, Howard TD, Keshavan MS, Kaczorowski J, Berry MN, Schoch K, Spence EJ, Kwapil TR. COMT and anxiety and cognition in children with chromosome 22q11.2 deletion syndrome. Psychiatry Res. 2010 Jul 30; 178(2):433-6.
    View in: PubMed
  81. Eack SM, Greenwald DP, Hogarty SS, Keshavan MS. One-year durability of the effects of cognitive enhancement therapy on functional outcome in early schizophrenia. Schizophr Res. 2010 Jul; 120(1-3):210-6.
    View in: PubMed
  82. Eack SM, Hogarty GE, Cho RY, Prasad KM, Greenwald DP, Hogarty SS, Keshavan MS. Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial. Arch Gen Psychiatry. 2010 Jul; 67(7):674-82.
    View in: PubMed
  83. Bhojraj TS, Sweeney JA, Prasad KM, Eack SM, Francis AN, Miewald JM, Montrose DM, Keshavan MS. Gray matter loss in young relatives at risk for schizophrenia: relation with prodromal psychopathology. Neuroimage. 2011 Jan; 54 Suppl 1:S272-9.
    View in: PubMed
  84. Jou RJ, Minshew NJ, Keshavan MS, Hardan AY. Cortical gyrification in autistic and Asperger disorders: a preliminary magnetic resonance imaging study. J Child Neurol. 2010 Dec; 25(12):1462-7.
    View in: PubMed
  85. Venkatasubramanian G, Jayakumar PN, Reddy VV, Reddy US, Gangadhar BN, Keshavan MS. Corpus callosum deficits in antipsychotic-naïve schizophrenia: evidence for neurodevelopmental pathogenesis. Psychiatry Res. 2010 May 30; 182(2):141-5.
    View in: PubMed
  86. Bhojraj TS, Francis AN, Montrose DM, Keshavan MS. Grey matter and cognitive deficits in young relatives of schizophrenia patients. Neuroimage. 2011 Jan; 54 Suppl 1:S287-92.
    View in: PubMed
  87. Keshavan MS, Kulkarni S, Bhojraj T, Francis A, Diwadkar V, Montrose DM, Seidman LJ, Sweeney J. Premorbid cognitive deficits in young relatives of schizophrenia patients. Front Hum Neurosci. 2010; 3:62.
    View in: PubMed
  88. Keshavan MS. Mnemonics for DSM-IV psychiatric disorders: Part II. Asian J Psychiatr. 2010 Mar; 3(1):41-2.
    View in: PubMed
  89. Yao JK, Dougherty GG, Reddy RD, Keshavan MS, Montrose DM, Matson WR, McEvoy J, Kaddurah-Daouk R. Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naïve patients with schizophrenia. PLoS One. 2010; 5(3):e9508.
    View in: PubMed
  90. Bhojraj TS, Prasad KM, Eack SM, Francis AN, Montrose DM, Keshavan MS. Do inter-regional gray-matter volumetric correlations reflect altered functional connectivity in high-risk offspring of schizophrenia patients? Schizophr Res. 2010 May; 118(1-3):62-8.
    View in: PubMed
  91. Jayakumar PN, Gangadhar BN, Venkatasubramanian G, Desai S, Velayudhan L, Subbakrishna D, Keshavan MS. High energy phosphate abnormalities normalize after antipsychotic treatment in schizophrenia: a longitudinal 31P MRS study of basal ganglia. Psychiatry Res. 2010 Mar 30; 181(3):237-40.
    View in: PubMed
  92. Prasad KM, Bamne MN, Shirts BH, Goradia D, Mannali V, Pancholi KM, Xue B, McClain L, Yolken RH, Keshavan MS, Nimgaonkar VL. Grey matter changes associated with host genetic variation and exposure to Herpes Simplex Virus 1 (HSV1) in first episode schizophrenia. Schizophr Res. 2010 May; 118(1-3):232-9.
    View in: PubMed
  93. Gilbert AM, Prasad K, Goradia D, Nutche J, Keshavan M, Frank E. Grey matter volume reductions in the emotion network of patients with depression and coronary artery disease. Psychiatry Res. 2010 Jan 30; 181(1):9-14.
    View in: PubMed
  94. Shashi V, Kwapil TR, Kaczorowski J, Berry MN, Santos CS, Howard TD, Goradia D, Prasad K, Vaibhav D, Rajarethinam R, Spence E, Keshavan MS. Evidence of gray matter reduction and dysfunction in chromosome 22q11.2 deletion syndrome. Psychiatry Res. 2010 Jan 30; 181(1):1-8.
    View in: PubMed
  95. Bhojraj TS, Diwadkar VA, Sweeney JA, Prasad KM, Eack SM, Montrose DM, Keshavan MS. Longitudinal alterations of executive function in non-psychotic adolescents at familial risk for schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Apr 16; 34(3):469-74.
    View in: PubMed
  96. Griebling J, Minshew NJ, Bodner K, Libove R, Bansal R, Konasale P, Keshavan MS, Hardan A. Dorsolateral prefrontal cortex magnetic resonance imaging measurements and cognitive performance in autism. J Child Neurol. 2010 Jul; 25(7):856-63.
    View in: PubMed
  97. Jindal RD, Pillai AK, Mahadik SP, Eklund K, Montrose DM, Keshavan MS. Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia. Schizophr Res. 2010 Jun; 119(1-3):47-51.
    View in: PubMed
  98. Murphy ER, Brent BK, Benton M, Pruitt P, Diwadkar V, Rajarethinam RP, Keshavan MS. Differential processing of metacognitive evaluation and the neural circuitry of the self and others in schizophrenia: a pilot study. Schizophr Res. 2010 Feb; 116(2-3):252-8.
    View in: PubMed
  99. Keshavan MS, Shrivastava A, Gangadhar BN. Early intervention in psychotic disorders: Challenges and relevance in the Indian context. Indian J Psychiatry. 2010 Jan; 52(Suppl 1):S153-8.
    View in: PubMed
  100. Siegle GJ, Condray R, Thase ME, Keshavan M, Steinhauer SR. Sustained gamma-band EEG following negative words in depression and schizophrenia. Int J Psychophysiol. 2010 Feb; 75(2):107-18.
    View in: PubMed
  101. Prasad KM, Goradia D, Eack S, Rajagopalan M, Nutche J, Magge T, Rajarethinam R, Keshavan MS. Cortical surface characteristics among offspring of schizophrenia subjects. Schizophr Res. 2010 Feb; 116(2-3):143-51.
    View in: PubMed
  102. Keshavan MS, Tandon R. Understanding evidence-based psychiatric practice and its application. Asian J Psychiatr. 2009 Dec; 2(4):123.
    View in: PubMed
  103. Harris MS, Reilly JL, Thase ME, Keshavan MS, Sweeney JA. Response suppression deficits in treatment-naïve first-episode patients with schizophrenia, psychotic bipolar disorder and psychotic major depression. Psychiatry Res. 2009 Dec 30; 170(2-3):150-6.
    View in: PubMed
  104. Condray R, Siegle GJ, Keshavan MS, Steinhauer SR. Effects of word frequency on semantic memory in schizophrenia: electrophysiological evidence for a deficit in linguistic access. Int J Psychophysiol. 2010 Feb; 75(2):141-56.
    View in: PubMed
  105. Kumra S, Asarnow R, Grace A, Keshavan M, McClellan J, Sikich L, Wagner A. From bench to bedside: translating new research from genetics and neuroimaging into treatment development for early-onset schizophrenia. Early Interv Psychiatry. 2009 Nov; 3(4):243-58.
    View in: PubMed
  106. Eack SM, Greenwald DP, Hogarty SS, Cooley SJ, DiBarry AL, Montrose DM, Keshavan MS. Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial. Psychiatr Serv. 2009 Nov; 60(11):1468-76.
    View in: PubMed
  107. Mansour HA, Talkowski ME, Wood J, Chowdari KV, McClain L, Prasad K, Montrose D, Fagiolini A, Friedman ES, Allen MH, Bowden CL, Calabrese J, El-Mallakh RS, Escamilla M, Faraone SV, Fossey MD, Gyulai L, Loftis JM, Hauser P, Ketter TA, Marangell LB, Miklowitz DJ, Nierenberg AA, Patel J, Sachs GS, Sklar P, Smoller JW, Laird N, Keshavan M, Thase ME, Axelson D, Birmaher B, Lewis D, Monk T, Frank E, Kupfer DJ, Devlin B, Nimgaonkar VL. Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. Bipolar Disord. 2009 Nov; 11(7):701-10.
    View in: PubMed
  108. Keshavan MS. Mnemonics for DSM-IV. Part I. Diagnostic criteria and psychiatric assessments. Asian J Psychiatr. 2009 Oct; 2(3):117-8.
    View in: PubMed
  109. Bhojraj TS, Francis AN, Rajarethinam R, Eack S, Kulkarni S, Prasad KM, Montrose DM, Dworakowski D, Diwadkar V, Keshavan MS. Verbal fluency deficits and altered lateralization of language brain areas in individuals genetically predisposed to schizophrenia. Schizophr Res. 2009 Dec; 115(2-3):202-8.
    View in: PubMed
  110. Lencer R, Reilly JL, Harris MS, Sprenger A, Keshavan MS, Sweeney JA. Sensorimotor transformation deficits for smooth pursuit in first-episode affective psychoses and schizophrenia. Biol Psychiatry. 2010 Feb 1; 67(3):217-23.
    View in: PubMed
  111. Hardan AY, Pabalan M, Gupta N, Bansal R, Melhem NM, Fedorov S, Keshavan MS, Minshew NJ. Corpus callosum volume in children with autism. Psychiatry Res. 2009 Oct 30; 174(1):57-61.
    View in: PubMed
  112. Keshavan MS, Dick RM, Diwadkar VA, Montrose DM, Prasad KM, Stanley JA. Striatal metabolic alterations in non-psychotic adolescent offspring at risk for schizophrenia: a (1)H spectroscopy study. Schizophr Res. 2009 Nov; 115(1):88-93.
    View in: PubMed
  113. Keshavan MS, Eack SM, Montrose DM, Abela MM, Bangalore SS, Diwadkar VA, Prasad KM. Do premorbid impairments predict emergent 'prodromal' symptoms in young relatives at risk for schizophrenia? Early Interv Psychiatry. 2009 Aug; 3(3):213-20.
    View in: PubMed
  114. Sanches M, Caetano S, Nicoletti M, Monkul ES, Chen HH, Hatch JP, Yeh PH, Mullis RL, Keshavan MS, Rajowska G, Soares JC. An MRI-based approach for the measurement of the dorsolateral prefrontal cortex in humans. Psychiatry Res. 2009 Aug 30; 173(2):150-4.
    View in: PubMed
  115. Jindal RD, Keshavan MS, Eklund K, Stevens A, Montrose DM, Yeragani VK. Beat-to-beat heart rate and QT interval variability in first episode neuroleptic-naive psychosis. Schizophr Res. 2009 Sep; 113(2-3):176-80.
    View in: PubMed
  116. McGorry PD, Nelson B, Amminger GP, Bechdolf A, Francey SM, Berger G, Riecher-Rössler A, Klosterkötter J, Ruhrmann S, Schultze-Lutter F, Nordentoft M, Hickie I, McGuire P, Berk M, Chen EY, Keshavan MS, Yung AR. Intervention in individuals at ultra-high risk for psychosis: a review and future directions. J Clin Psychiatry. 2009 Sep; 70(9):1206-12.
    View in: PubMed
  117. Boutros NN, Brockhaus-Dumke A, Gjini K, Vedeniapin A, Elfakhani M, Burroughs S, Keshavan M. Sensory-gating deficit of the N100 mid-latency auditory evoked potential in medicated schizophrenia patients. Schizophr Res. 2009 Sep; 113(2-3):339-46.
    View in: PubMed
  118. Hardan AY, Libove RA, Keshavan MS, Melhem NM, Minshew NJ. A preliminary longitudinal magnetic resonance imaging study of brain volume and cortical thickness in autism. Biol Psychiatry. 2009 Aug 15; 66(4):320-6.
    View in: PubMed
  119. Eack SM, Pogue-Geile MF, Greeno CG, Keshavan MS. Evidence of factorial variance of the Mayer-Salovey-Caruso Emotional Intelligence Test across schizophrenia and normative samples. Schizophr Res. 2009 Oct; 114(1-3):105-9.
    View in: PubMed
  120. Keshavan MS. Asian pearls. Asian J Psychiatr. 2009 Jun; 2(2):83.
    View in: PubMed
  121. Bangalore SS, Goradia DD, Nutche J, Diwadkar VA, Prasad KM, Keshavan MS. Untreated illness duration correlates with gray matter loss in first-episode psychoses. Neuroreport. 2009 May 6; 20(7):729-34.
    View in: PubMed
  122. Yao JK, Dougherty GG, Reddy RD, Keshavan MS, Montrose DM, Matson WR, Rozen S, Krishnan RR, McEvoy J, Kaddurah-Daouk R. Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia. Mol Psychiatry. 2010 Sep; 15(9):938-53.
    View in: PubMed
  123. Eack SM, Mermon DE, Montrose DM, Miewald J, Gur RE, Gur RC, Sweeney JA, Keshavan MS. Social cognition deficits among individuals at familial high risk for schizophrenia. Schizophr Bull. 2010 Nov; 36(6):1081-8.
    View in: PubMed
  124. Tandon R, Nasrallah HA, Keshavan MS. Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophr Res. 2009 May; 110(1-3):1-23.
    View in: PubMed
  125. Nery FG, Chen HH, Hatch JP, Nicoletti MA, Brambilla P, Sassi RB, Mallinger AG, Keshavan MS, Soares JC. Orbitofrontal cortex gray matter volumes in bipolar disorder patients: a region-of-interest MRI study. Bipolar Disord. 2009 Mar; 11(2):145-53.
    View in: PubMed
  126. Kalyanasundaram S, Keshavan MS. Medical education corner They taught us. Asian J Psychiatr. 2009 Mar; 2(1):44-7.
    View in: PubMed
  127. Keary CJ, Minshew NJ, Bansal R, Goradia D, Fedorov S, Keshavan MS, Hardan AY. Corpus callosum volume and neurocognition in autism. J Autism Dev Disord. 2009 Jun; 39(6):834-41.
    View in: PubMed
  128. Nasrallah HA, Keshavan MS, Benes FM, Braff DL, Green AI, Gur RE, Kane JM, Perkins DO, Weiden PJ, Weinberger DR, Correll CU. Proceedings and data from The Schizophrenia Summit: a critical appraisal to improve the management of Schizophrenia. J Clin Psychiatry. 2009; 70 Suppl 1:4-46.
    View in: PubMed
  129. Rajarethinam R, Dziuba J, Manji S, Pizzuti A, Lachover L, Keshavan M. Use of aripiprazole in tardive dyskinesia: an open label study of six cases. World J Biol Psychiatry. 2009; 10(4 Pt 2):416-9.
    View in: PubMed
  130. Venkatasubramanian G, Jayakumar PN, Gangadhar BN, Keshavan MS. Neuroanatomical correlates of neurological soft signs in antipsychotic-naive schizophrenia. Psychiatry Res. 2008 Dec 30; 164(3):215-22.
    View in: PubMed
  131. Prasad KM, Sanders R, Sweeney J, Montrose D, Diwadkar V, Dworakowski D, Miewald J, Keshavan M. Neurological abnormalities among offspring of persons with schizophrenia: relation to premorbid psychopathology. Schizophr Res. 2009 Mar; 108(1-3):163-9.
    View in: PubMed
  132. Stanley JA, Kipp H, Greisenegger E, MacMaster FP, Panchalingam K, Keshavan MS, Bukstein OG, Pettegrew JW. Evidence of developmental alterations in cortical and subcortical regions of children with attention-deficit/hyperactivity disorder: a multivoxel in vivo phosphorus 31 spectroscopy study. Arch Gen Psychiatry. 2008 Dec; 65(12):1419-28.
    View in: PubMed
  133. Keshavan MS. Psychiatric classifications across the world: Challenges and opportunities. Asian J Psychiatr. 2008 Dec; 1(2):21.
    View in: PubMed
  134. Paus T, Keshavan M, Giedd JN. Why do many psychiatric disorders emerge during adolescence? Nat Rev Neurosci. 2008 Dec; 9(12):947-57.
    View in: PubMed
  135. Hill SY, Wang S, Kostelnik B, Carter H, Holmes B, McDermott M, Zezza N, Stiffler S, Keshavan MS. Disruption of orbitofrontal cortex laterality in offspring from multiplex alcohol dependence families. Biol Psychiatry. 2009 Jan 15; 65(2):129-36.
    View in: PubMed
  136. Lencer R, Sprenger A, Harris MS, Reilly JL, Keshavan MS, Sweeney JA. Effects of second-generation antipsychotic medication on smooth pursuit performance in antipsychotic-naive schizophrenia. Arch Gen Psychiatry. 2008 Oct; 65(10):1146-54.
    View in: PubMed
  137. Jou RJ, Minshew NJ, Melhem NM, Keshavan MS, Hardan AY. Brainstem volumetric alterations in children with autism. Psychol Med. 2009 Aug; 39(8):1347-54.
    View in: PubMed
  138. Keshavan MS, Tandon R, Boutros NN, Nasrallah HA. Schizophrenia, "just the facts": what we know in 2008 Part 3: neurobiology. Schizophr Res. 2008 Dec; 106(2-3):89-107.
    View in: PubMed
  139. Tandon R, Javed A, Deva P, Weizman A, Kronfol Z, D'Souza R, Gangadhar BN, Kapur S, Akiskal H, Tsuang M, Keshavan M. Disaster mental health in Asia and the Asian Journal of Psychiatry. Asian J Psychiatr. 2008 Sep; 1(1):5-6.
    View in: PubMed
  140. Eack SM, Prasad KM, Montrose DM, Goradia DD, Dworakowski D, Miewald J, Keshavan MS. An integrated psychobiological predictive model of emergent psychopathology among young relatives at risk for schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12; 32(8):1873-8.
    View in: PubMed
  141. Keshavan MS. An international journal for psychiatry in Asia. Asian J Psychiatr. 2008 Sep; 1(1):4.
    View in: PubMed
  142. Eack SM, Greeno CG, Pogue-Geile MF, Newhill CE, Hogarty GE, Keshavan MS. Assessing social-cognitive deficits in schizophrenia with the Mayer-Salovey-Caruso Emotional Intelligence Test. Schizophr Bull. 2010 Mar; 36(2):370-80.
    View in: PubMed
  143. Eack SM, George MM, Prasad KM, Keshavan MS. Neuroanatomical substrates of foresight in schizophrenia. Schizophr Res. 2008 Aug; 103(1-3):62-70.
    View in: PubMed
  144. Jindal RD, Keshavan MS. Neurobiology of the early course of schizophrenia. Expert Rev Neurother. 2008 Jul; 8(7):1093-100.
    View in: PubMed
  145. Diwadkar VA, Flaugher B, Jones T, Zalányi L, Ujfalussy B, Keshavan MS, Erdi P. Impaired associative learning in schizophrenia: behavioral and computational studies. Cogn Neurodyn. 2008 Sep; 2(3):207-19.
    View in: PubMed
  146. Harris MS, Wiseman CL, Reilly JL, Keshavan MS, Sweeney JA. Effects of risperidone on procedural learning in antipsychotic-naive first-episode schizophrenia. Neuropsychopharmacology. 2009 Jan; 34(2):468-76.
    View in: PubMed
  147. Tandon R, Keshavan MS, Nasrallah HA. Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology. Schizophr Res. 2008 Jul; 102(1-3):1-18.
    View in: PubMed
  148. Venkatasubramanian G, Jayakumar PN, Gangadhar BN, Keshavan MS. Automated MRI parcellation study of regional volume and thickness of prefrontal cortex (PFC) in antipsychotic-naïve schizophrenia. Acta Psychiatr Scand. 2008 Jun; 117(6):420-31.
    View in: PubMed
  149. Hardan AY, Minshew NJ, Melhem NM, Srihari S, Jo B, Bansal R, Keshavan MS, Stanley JA. An MRI and proton spectroscopy study of the thalamus in children with autism. Psychiatry Res. 2008 Jul 15; 163(2):97-105.
    View in: PubMed
  150. Sanches M, Keshavan MS, Brambilla P, Soares JC. Neurodevelopmental basis of bipolar disorder: a critical appraisal. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Oct 1; 32(7):1617-27.
    View in: PubMed
  151. Keshavan M, Montrose DM, Rajarethinam R, Diwadkar V, Prasad K, Sweeney JA. Psychopathology among offspring of parents with schizophrenia: relationship to premorbid impairments. Schizophr Res. 2008 Aug; 103(1-3):114-20.
    View in: PubMed
  152. Meda SA, Giuliani NR, Calhoun VD, Jagannathan K, Schretlen DJ, Pulver A, Cascella N, Keshavan M, Kates W, Buchanan R, Sharma T, Pearlson GD. A large scale (N=400) investigation of gray matter differences in schizophrenia using optimized voxel-based morphometry. Schizophr Res. 2008 Apr; 101(1-3):95-105.
    View in: PubMed
  153. Prasad KM, Keshavan MS. Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"? Schizophr Bull. 2008 Jul; 34(4):774-90.
    View in: PubMed
  154. Gilbert AR, Mataix-Cols D, Almeida JR, Lawrence N, Nutche J, Diwadkar V, Keshavan MS, Phillips ML. Brain structure and symptom dimension relationships in obsessive-compulsive disorder: a voxel-based morphometry study. J Affect Disord. 2008 Jul; 109(1-2):117-26.
    View in: PubMed
  155. Eack SM, Keshavan MS. Foresight in schizophrenia: a potentially unique and relevant factor to functional disability. Psychiatr Serv. 2008 Mar; 59(3):256-60.
    View in: PubMed
  156. Tandon R, Keshavan MS, Nasrallah HA. Schizophrenia, "Just the Facts": what we know in 2008 part 1: overview. Schizophr Res. 2008 Mar; 100(1-3):4-19.
    View in: PubMed
  157. Gilbert AR, Keshavan MS, Diwadkar V, Nutche J, Macmaster F, Easter PC, Buhagiar CJ, Rosenberg DR. Gray matter differences between pediatric obsessive-compulsive disorder patients and high-risk siblings: a preliminary voxel-based morphometry study. Neurosci Lett. 2008 Apr 11; 435(1):45-50.
    View in: PubMed
  158. Reilly JL, Harris MS, Khine TT, Keshavan MS, Sweeney JA. Reduced attentional engagement contributes to deficits in prefrontal inhibitory control in schizophrenia. Biol Psychiatry. 2008 Apr 15; 63(8):776-83.
    View in: PubMed
  159. Bangalore SS, Prasad KM, Montrose DM, Goradia DD, Diwadkar VA, Keshavan MS. Cannabis use and brain structural alterations in first episode schizophrenia--a region of interest, voxel based morphometric study. Schizophr Res. 2008 Feb; 99(1-3):1-6.
    View in: PubMed
  160. Rajarethinam R, Sohi J, Arfken C, Keshavan MS. No difference in the prevalence of cavum septum pellucidum (CSP) between first-episode schizophrenia patients, offspring of schizophrenia patients and healthy controls. Schizophr Res. 2008 Aug; 103(1-3):22-5.
    View in: PubMed
  161. Jindal RD, Keshavan MS. Classifying antipsychotic agents : need for new terminology. CNS Drugs. 2008; 22(12):1047-59.
    View in: PubMed
  162. Keshavan MS, Prasad KM, Montrose DM, Miewald JM, Kupfer DJ. Sleep quality and architecture in quetiapine, risperidone, or never-treated schizophrenia patients. J Clin Psychopharmacol. 2007 Dec; 27(6):703-5.
    View in: PubMed
  163. Hill SY, Kostelnik B, Holmes B, Goradia D, McDermott M, Diwadkar V, Keshavan M. fMRI BOLD response to the eyes task in offspring from multiplex alcohol dependence families. Alcohol Clin Exp Res. 2007 Dec; 31(12):2028-35.
    View in: PubMed
  164. Caetano SC, Silveira CM, Kaur S, Nicoletti M, Hatch JP, Brambilla P, Sassi R, Axelson D, Keshavan MS, Ryan ND, Birmaher B, Soares JC. Abnormal corpus callosum myelination in pediatric bipolar patients. J Affect Disord. 2008 Jun; 108(3):297-301.
    View in: PubMed
  165. Monkul ES, Hatch JP, Sassi RB, Axelson D, Brambilla P, Nicoletti MA, Keshavan MS, Ryan ND, Birmaher B, Soares JC. MRI study of the cerebellum in young bipolar patients. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1; 32(3):613-9.
    View in: PubMed
  166. Rajarethinam R, Upadhyaya A, Tsou P, Upadhyaya M, Keshavan MS. Caudate volume in offspring of patients with schizophrenia. Br J Psychiatry. 2007 Sep; 191:258-9.
    View in: PubMed
  167. Keshavan MS, Prasad KM, Pearlson G. Are brain structural abnormalities useful as endophenotypes in schizophrenia? Int Rev Psychiatry. 2007 Aug; 19(4):397-406.
    View in: PubMed
  168. Shad MU, Keshavan MS, Tamminga CA, Cullum CM, David A. Neurobiological underpinnings of insight deficits in schizophrenia. Int Rev Psychiatry. 2007 Aug; 19(4):437-46.
    View in: PubMed
  169. Keshavan MS, Amirsadri A. Early intervention in schizophrenia: current and future perspectives. Curr Psychiatry Rep. 2007 Aug; 9(4):325-8.
    View in: PubMed
  170. Hardan AY, Girgis RR, Adams J, Gilbert AR, Melhem NM, Keshavan MS, Minshew NJ. Brief report: abnormal association between the thalamus and brain size in Asperger's disorder. J Autism Dev Disord. 2008 Feb; 38(2):390-4.
    View in: PubMed
  171. Zanetti MV, Soloff PH, Nicoletti MA, Hatch JP, Brambilla P, Keshavan MS, Soares JC. MRI study of corpus callosum in patients with borderline personality disorder: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Oct 1; 31(7):1519-25.
    View in: PubMed
  172. Gur RE, Keshavan MS, Lawrie SM. Deconstructing psychosis with human brain imaging. Schizophr Bull. 2007 Jul; 33(4):921-31.
    View in: PubMed
  173. Reddy RD, Keshavan MS, Yao JK. Reduced platelet serotonergic responsivity as assessed by dense granule secretion in first-episode psychosis. Clin Biochem. 2007 Sep; 40(13-14):1081-3.
    View in: PubMed
  174. Stanley JA, Vemulapalli M, Nutche J, Montrose DM, Sweeney JA, Pettegrew JW, MacMaster FP, Keshavan MS. Reduced N-acetyl-aspartate levels in schizophrenia patients with a younger onset age: a single-voxel 1H spectroscopy study. Schizophr Res. 2007 Jul; 93(1-3):23-32.
    View in: PubMed
  175. Strassnig M, Miewald J, Keshavan M, Ganguli R. Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis. Schizophr Res. 2007 Jul; 93(1-3):90-8.
    View in: PubMed
  176. Jindal RD, Keshavan MS. Heart rate variability in patients with depression. Arch Gen Psychiatry. 2007 May; 64(5):611-2.
    View in: PubMed
  177. Mamo D, Kapur S, Keshavan M, Laruelle M, Taylor CC, Kothare PA, Barsoum P, McDonnell D. D2 receptor occupancy of olanzapine pamoate depot using positron emission tomography: an open-label study in patients with schizophrenia. Neuropsychopharmacology. 2008 Jan; 33(2):298-304.
    View in: PubMed
  178. Rubin LH, Haas GL, Keshavan MS, Sweeney JA, Maki PM. Sex difference in cognitive response to antipsychotic treatment in first episode schizophrenia. Neuropsychopharmacology. 2008 Jan; 33(2):290-7.
    View in: PubMed
  179. MacMaster FP, El-Sheikh R, Upadhyaya AR, Nutche J, Rosenberg DR, Keshavan M. Effect of antipsychotics on pituitary gland volume in treatment-naïve first-episode schizophrenia: a pilot study. Schizophr Res. 2007 May; 92(1-3):207-10.
    View in: PubMed
  180. Reilly JL, Harris MS, Khine TT, Keshavan MS, Sweeney JA. Antipsychotic drugs exacerbate impairment on a working memory task in first-episode schizophrenia. Biol Psychiatry. 2007 Oct 1; 62(7):818-21.
    View in: PubMed
  181. Jindal RD, Keshavan MS. Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders: response to Cohen et al. Diabetes Care. 2007 Feb; 30(2):446-7; author reply 447-8.
    View in: PubMed
  182. Lacerda AL, Hardan AY, Yorbik O, Vemulapalli M, Prasad KM, Keshavan MS. Morphology of the orbitofrontal cortex in first-episode schizophrenia: relationship with negative symptomatology. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30; 31(2):510-6.
    View in: PubMed
  183. Reddy R, Keshavan M, Yao JK. Blunted serotonergic responsivity in neuroleptic-naïve patients at first-episode of schizophrenia. Schizophr Res. 2007 Feb; 90(1-3):81-5.
    View in: PubMed
  184. Wittmann D, Keshavan M. Grief and mourning in schizophrenia. Psychiatry. 2007; 70(2):154-66.
    View in: PubMed
  185. Upadhyaya AR, El-Sheikh R, MacMaster FP, Diwadkar VA, Keshavan MS. Pituitary volume in neuroleptic-naïve schizophrenia: a structural MRI study. Schizophr Res. 2007 Feb; 90(1-3):266-73.
    View in: PubMed
  186. Sanjuan J, Lull JJ, Aguilar EJ, Martí-Bonmatí L, Moratal D, Gonzalez JC, Robles M, Keshavan MS. Emotional words induce enhanced brain activity in schizophrenic patients with auditory hallucinations. Psychiatry Res. 2007 Jan 15; 154(1):21-9.
    View in: PubMed
  187. Monkul ES, Hatch JP, Nicoletti MA, Spence S, Brambilla P, Lacerda AL, Sassi RB, Mallinger AG, Keshavan MS, Soares JC. Fronto-limbic brain structures in suicidal and non-suicidal female patients with major depressive disorder. Mol Psychiatry. 2007 Apr; 12(4):360-6.
    View in: PubMed
  188. MacMaster FP, Keshavan M, Mirza Y, Carrey N, Upadhyaya AR, El-Sheikh R, Buhagiar CJ, Taormina SP, Boyd C, Lynch M, Rose M, Ivey J, Moore GJ, Rosenberg DR. Development and sexual dimorphism of the pituitary gland. Life Sci. 2007 Feb 13; 80(10):940-4.
    View in: PubMed
  189. Stanley JA, Kipp H, Greisenegger E, MacMaster FP, Panchalingam K, Pettegrew JW, Keshavan MS, Bukstein OG. Regionally specific alterations in membrane phospholipids in children with ADHD: An in vivo 31P spectroscopy study. Psychiatry Res. 2006 Dec 1; 148(2-3):217-21.
    View in: PubMed
  190. Jayakumar PN, Venkatasubramanian G, Keshavan MS, Srinivas JS, Gangadhar BN. MRI volumetric and 31P MRS metabolic correlates of caudate nucleus in antipsychotic-naïve schizophrenia. Acta Psychiatr Scand. 2006 Nov; 114(5):346-51.
    View in: PubMed
  191. Reilly JL, Harris MS, Keshavan MS, Sweeney JA. Adverse effects of risperidone on spatial working memory in first-episode schizophrenia. Arch Gen Psychiatry. 2006 Nov; 63(11):1189-97.
    View in: PubMed
  192. Eack SM, Hogarty GE, Greenwald DP, Hogarty SS, Keshavan MS. Cognitive enhancement therapy improves emotional intelligence in early course schizophrenia: preliminary effects. Schizophr Res. 2007 Jan; 89(1-3):308-11.
    View in: PubMed
  193. Prasad KM, Shirts BH, Yolken RH, Keshavan MS, Nimgaonkar VL. Brain morphological changes associated with exposure to HSV1 in first-episode schizophrenia. Mol Psychiatry. 2007 Jan; 12(1):105-13, 1.
    View in: PubMed
  194. Hardan AY, Girgis RR, Lacerda AL, Yorbik O, Kilpatrick M, Keshavan MS, Minshew NJ. Magnetic resonance imaging study of the orbitofrontal cortex in autism. J Child Neurol. 2006 Oct; 21(10):866-71.
    View in: PubMed
  195. Jindal RD, Keshavan MS. Critical role of M3 muscarinic receptor in insulin secretion: implications for psychopharmacology. J Clin Psychopharmacol. 2006 Oct; 26(5):449-50.
    View in: PubMed
  196. Hardan AY, Girgis RR, Adams J, Gilbert AR, Keshavan MS, Minshew NJ. Abnormal brain size effect on the thalamus in autism. Psychiatry Res. 2006 Oct 30; 147(2-3):145-51.
    View in: PubMed
  197. Keshavan MS, Roberts M, Wittmann D. Guidelines for clinical treatment of early course schizophrenia. Curr Psychiatry Rep. 2006 Aug; 8(4):329-34.
    View in: PubMed
  198. MacMaster FP, Russell A, Mirza Y, Keshavan MS, Taormina SP, Bhandari R, Boyd C, Lynch M, Rose M, Ivey J, Moore GJ, Rosenberg DR. Pituitary volume in treatment-naïve pediatric major depressive disorder. Biol Psychiatry. 2006 Oct 15; 60(8):862-6.
    View in: PubMed
  199. Girgis RR, Minshew NJ, Melhem NM, Nutche JJ, Keshavan MS, Hardan AY. Volumetric alterations of the orbitofrontal cortex in autism. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30; 31(1):41-5.
    View in: PubMed
  200. Sanders RD, Joo YH, Almasy L, Wood J, Keshavan MS, Pogue-Geile MF, Gur RC, Gur RE, Nimgaonkar VL. Are neurologic examination abnormalities heritable? A preliminary study. Schizophr Res. 2006 Sep; 86(1-3):172-80.
    View in: PubMed
  201. Shad MU, Tamminga CA, Cullum M, Haas GL, Keshavan MS. Insight and frontal cortical function in schizophrenia: a review. Schizophr Res. 2006 Sep; 86(1-3):54-70.
    View in: PubMed
  202. Merritt-Davis OB, Keshavan MS. Pathways to care for African Americans with early psychosis. Psychiatr Serv. 2006 Jul; 57(7):1043-4.
    View in: PubMed
  203. Hardan AY, Muddasani S, Vemulapalli M, Keshavan MS, Minshew NJ. An MRI study of increased cortical thickness in autism. Am J Psychiatry. 2006 Jul; 163(7):1290-2.
    View in: PubMed
  204. Hardan AY, Keshavan MS, Sreedhar S, Vemulapalli M, Minshew NJ. An MRI study of minor physical anomalies in autism. J Autism Dev Disord. 2006 Jul; 36(5):607-11.
    View in: PubMed
  205. Rao A, Keshavan MS. Can psychiatrists recognize mental illness in paintings? Am J Psychiatry. 2006 Apr; 163(4):599.
    View in: PubMed
  206. Hill SY, Muddasani S, Prasad K, Nutche J, Steinhauer SR, Scanlon J, McDermott M, Keshavan M. Cerebellar volume in offspring from multiplex alcohol dependence families. Biol Psychiatry. 2007 Jan 1; 61(1):41-7.
    View in: PubMed
  207. Gangadhar BN, Jayakumar PN, Venkatasubramanian G, Janakiramaiah N, Keshavan MS. Developmental reflexes and 31P Magnetic Resonance Spectroscopy of basal ganglia in antipsychotic-naive schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jul; 30(5):910-3.
    View in: PubMed
  208. Shashi V, Keshavan MS, Howard TD, Berry MN, Basehore MJ, Lewandowski E, Kwapil TR. Cognitive correlates of a functional COMT polymorphism in children with 22q11.2 deletion syndrome. Clin Genet. 2006 Mar; 69(3):234-8.
    View in: PubMed
  209. Girgis RR, Diwadkar VA, Nutche JJ, Sweeney JA, Keshavan MS, Hardan AY. Risperidone in first-episode psychosis: a longitudinal, exploratory voxel-based morphometric study. Schizophr Res. 2006 Feb 15; 82(1):89-94.
    View in: PubMed
  210. Caetano SC, Kaur S, Brambilla P, Nicoletti M, Hatch JP, Sassi RB, Mallinger AG, Keshavan MS, Kupfer DJ, Frank E, Soares JC. Smaller cingulate volumes in unipolar depressed patients. Biol Psychiatry. 2006 Apr 15; 59(8):702-6.
    View in: PubMed
  211. Harris MS, Reilly JL, Keshavan MS, Sweeney JA. Longitudinal studies of antisaccades in antipsychotic-naive first-episode schizophrenia. Psychol Med. 2006 Apr; 36(4):485-94.
    View in: PubMed
  212. Monkul ES, Nicoletti MA, Spence D, Sassi RB, Axelson D, Brambilla P, Hatch JP, Keshavan M, Ryan N, Birmaher B, Soares JC. MRI study of thalamus volumes in juvenile patients with bipolar disorder. Depress Anxiety. 2006; 23(6):347-52.
    View in: PubMed
  213. Shad MU, Muddasani S, Keshavan MS. Prefrontal subregions and dimensions of insight in first-episode schizophrenia--a pilot study. Psychiatry Res. 2006 Jan 30; 146(1):35-42.
    View in: PubMed
  214. Yeragani VK, Cashmere D, Miewald J, Tancer M, Keshavan MS. Decreased coherence in higher frequency ranges (beta and gamma) between central and frontal EEG in patients with schizophrenia: A preliminary report. Psychiatry Res. 2006 Jan 30; 141(1):53-60.
    View in: PubMed
  215. Yasar AS, Monkul ES, Sassi RB, Axelson D, Brambilla P, Nicoletti MA, Hatch JP, Keshavan M, Ryan N, Birmaher B, Soares JC. MRI study of corpus callosum in children and adolescents with bipolar disorder. Psychiatry Res. 2006 Jan 30; 146(1):83-5.
    View in: PubMed
  216. Diwadkar VA, Montrose DM, Dworakowski D, Sweeney JA, Keshavan MS. Genetically predisposed offspring with schizotypal features: an ultra high-risk group for schizophrenia? Prog Neuropsychopharmacol Biol Psychiatry. 2006 Mar; 30(2):230-8.
    View in: PubMed
  217. Keshavan MS, Diwadkar VA, Montrose DM, Rajarethinam R, Sweeney JA. Premorbid indicators and risk for schizophrenia: a selective review and update. Schizophr Res. 2005 Nov 1; 79(1):45-57.
    View in: PubMed
  218. Sassi RB, Stanley JA, Axelson D, Brambilla P, Nicoletti MA, Keshavan MS, Ramos RT, Ryan N, Birmaher B, Soares JC. Reduced NAA levels in the dorsolateral prefrontal cortex of young bipolar patients. Am J Psychiatry. 2005 Nov; 162(11):2109-15.
    View in: PubMed
  219. Prasad KM, Sahni SD, Rohm BR, Keshavan MS. Dorsolateral prefrontal cortex morphology and short-term outcome in first-episode schizophrenia. Psychiatry Res. 2005 Nov 30; 140(2):147-55.
    View in: PubMed
  220. Keshavan MS, Diwadkar V, Rosenberg DR. Developmental biomarkers in schizophrenia and other psychiatric disorders: common origins, different trajectories? Epidemiol Psichiatr Soc. 2005 Oct-Dec; 14(4):188-93.
    View in: PubMed
  221. MacMaster FP, Russell A, Mirza Y, Keshavan MS, Banerjee SP, Bhandari R, Boyd C, Lynch M, Rose M, Ivey J, Moore GJ, Rosenberg DR. Pituitary volume in pediatric obsessive-compulsive disorder. Biol Psychiatry. 2006 Feb 1; 59(3):252-7.
    View in: PubMed
  222. De Bellis MD, Narasimhan A, Thatcher DL, Keshavan MS, Soloff P, Clark DB. Prefrontal cortex, thalamus, and cerebellar volumes in adolescents and young adults with adolescent-onset alcohol use disorders and comorbid mental disorders. Alcohol Clin Exp Res. 2005 Sep; 29(9):1590-600.
    View in: PubMed
  223. Kaur S, Sassi RB, Axelson D, Nicoletti M, Brambilla P, Monkul ES, Hatch JP, Keshavan MS, Ryan N, Birmaher B, Soares JC. Cingulate cortex anatomical abnormalities in children and adolescents with bipolar disorder. Am J Psychiatry. 2005 Sep; 162(9):1637-43.
    View in: PubMed
  224. Keshavan MS, Berger G, Zipursky RB, Wood SJ, Pantelis C. Neurobiology of early psychosis. Br J Psychiatry Suppl. 2005 Aug; 48:s8-18.
    View in: PubMed
  225. Brambilla P, Cerini R, Gasparini A, Versace A, Andreone N, Vittorini E, Barbui C, Pelizza L, Nosè M, Barlocco L, Marrella G, Gregis M, Tournikioti K, David AS, Keshavan MS, Tansella M. Investigation of corpus callosum in schizophrenia with diffusion imaging. Schizophr Res. 2005 Nov 15; 79(2-3):201-10.
    View in: PubMed
  226. Goldstein G, Sanders RD, Forman SD, Tarpey T, Gurklis JA, Van Kammen DP, Keshavan MS. The effects of antipsychotic medication on factor and cluster structure of neurologic examination abnormalities in schizophrenia. Schizophr Res. 2005 Jun 1; 75(1):55-64.
    View in: PubMed
  227. Brambilla P, Stanley JA, Nicoletti MA, Sassi RB, Mallinger AG, Frank E, Kupfer D, Keshavan MS, Soares JC. 1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients. J Affect Disord. 2005 May; 86(1):61-7.
    View in: PubMed
  228. Lacerda AL, Caetano D, Keshavan MS. Urinary pH in panic disorder. Psychiatry Res. 2005 Apr 15; 134(2):199-203.
    View in: PubMed
  229. Jayakumar PN, Venkatasubramanian G, Gangadhar BN, Janakiramaiah N, Keshavan MS. Optimized voxel-based morphometry of gray matter volume in first-episode, antipsychotic-naive schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2005 May; 29(4):587-91.
    View in: PubMed
  230. Sanches M, Roberts RL, Sassi RB, Axelson D, Nicoletti M, Brambilla P, Hatch JP, Keshavan MS, Ryan ND, Birmaher B, Soares JC. Developmental abnormalities in striatum in young bipolar patients: a preliminary study. Bipolar Disord. 2005 Apr; 7(2):153-8.
    View in: PubMed
  231. Brambilla P, Stanley JA, Nicoletti MA, Sassi RB, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC. 1H Magnetic resonance spectroscopy study of dorsolateral prefrontal cortex in unipolar mood disorder patients. Psychiatry Res. 2005 Feb 28; 138(2):131-9.
    View in: PubMed
  232. Duggal HS, Muddasani S, Keshavan MS. Insular volumes in first-episode schizophrenia: gender effect. Schizophr Res. 2005 Feb 1; 73(1):113-20.
    View in: PubMed
  233. Prasad KM, Chowdari KV, Nimgaonkar VL, Talkowski ME, Lewis DA, Keshavan MS. Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patients. Mol Psychiatry. 2005 Feb; 10(2):213-9.
    View in: PubMed
  234. Sanders RD, Allen DN, D Forman S, Tarpey T, Keshavan MS, Goldstein G. Confirmatory factor analysis of the Neurological Evaluation Scale in unmedicated schizophrenia. Psychiatry Res. 2005 Jan 30; 133(1):65-71.
    View in: PubMed
  235. Sanches M, Sassi RB, Axelson D, Nicoletti M, Brambilla P, Hatch JP, Keshavan MS, Ryan ND, Birmaher B, Soares JC. Subgenual prefrontal cortex of child and adolescent bipolar patients: a morphometric magnetic resonance imaging study. Psychiatry Res. 2005 Jan 30; 138(1):43-9.
    View in: PubMed
  236. Reilly JL, Harris MS, Keshavan MS, Sweeney JA. Abnormalities in visually guided saccades suggest corticofugal dysregulation in never-treated schizophrenia. Biol Psychiatry. 2005 Jan 15; 57(2):145-54.
    View in: PubMed
  237. Yao JK, Thomas EA, Reddy RD, Keshavan MS. Association of plasma apolipoproteins D with RBC membrane arachidonic acid levels in schizophrenia. Schizophr Res. 2005 Jan 1; 72(2-3):259-66.
    View in: PubMed
  238. Keshavan MS, Duggal HS, Veeragandham G, McLaughlin NM, Montrose DM, Haas GL, Schooler NR. Personality dimensions in first-episode psychoses. Am J Psychiatry. 2005 Jan; 162(1):102-9.
    View in: PubMed
  239. Lacerda AL, Brambilla P, Sassi RB, Nicoletti MA, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC. Anatomical MRI study of corpus callosum in unipolar depression. J Psychiatr Res. 2005 Jul; 39(4):347-54.
    View in: PubMed
  240. Jou RJ, Hardan AY, Keshavan MS. Reduced cortical folding in individuals at high risk for schizophrenia: a pilot study. Schizophr Res. 2005 Jun 15; 75(2-3):309-13.
    View in: PubMed
  241. Caetano SC, Hatch JP, Brambilla P, Sassi RB, Nicoletti M, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC. Anatomical MRI study of hippocampus and amygdala in patients with current and remitted major depression. Psychiatry Res. 2004 Dec 15; 132(2):141-7.
    View in: PubMed
  242. Keshavan MS, Cashmere JD, Miewald J, Yeragani VK. Decreased nonlinear complexity and chaos during sleep in first episode schizophrenia: a preliminary report. Schizophr Res. 2004 Dec 1; 71(2-3):263-72.
    View in: PubMed
  243. Keshavan M, Shad M, Soloff P, Schooler N. Efficacy and tolerability of olanzapine in the treatment of schizotypal personality disorder. Schizophr Res. 2004 Nov 1; 71(1):97-101.
    View in: PubMed
  244. Keshavan MS, Rabinowitz J, DeSmedt G, Harvey PD, Schooler N. Correlates of insight in first episode psychosis. Schizophr Res. 2004 Oct 1; 70(2-3):187-94.
    View in: PubMed
  245. Keshavan MS, Diwadkar VA, Montrose DM, Stanley JA, Pettegrew JW. Premorbid characterization in schizophrenia: the Pittsburgh High Risk Study. World Psychiatry. 2004 Oct; 3(3):163-8.
    View in: PubMed
  246. Sassi RB, Brambilla P, Hatch JP, Nicoletti MA, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC. Reduced left anterior cingulate volumes in untreated bipolar patients. Biol Psychiatry. 2004 Oct 1; 56(7):467-75.
    View in: PubMed
  247. Brambilla P, Stanley JA, Sassi RB, Nicoletti MA, Mallinger AG, Keshavan MS, Soares JC. 1H MRS study of dorsolateral prefrontal cortex in healthy individuals before and after lithium administration. Neuropsychopharmacology. 2004 Oct; 29(10):1918-24.
    View in: PubMed
  248. Hardan AY, Jou RJ, Keshavan MS, Varma R, Minshew NJ. Increased frontal cortical folding in autism: a preliminary MRI study. Psychiatry Res. 2004 Sep 15; 131(3):263-8.
    View in: PubMed
  249. Chen BK, Sassi R, Axelson D, Hatch JP, Sanches M, Nicoletti M, Brambilla P, Keshavan MS, Ryan ND, Birmaher B, Soares JC. Cross-sectional study of abnormal amygdala development in adolescents and young adults with bipolar disorder. Biol Psychiatry. 2004 Sep 15; 56(6):399-405.
    View in: PubMed
  250. Prasad KM, Patel AR, Muddasani S, Sweeney J, Keshavan MS. The entorhinal cortex in first-episode psychotic disorders: a structural magnetic resonance imaging study. Am J Psychiatry. 2004 Sep; 161(9):1612-9.
    View in: PubMed
  251. Diwadkar VA, Prasad KM, Keshavan MS. Approaches for adolescents with an affected family member with schizophrenia. Curr Psychiatry Rep. 2004 Aug; 6(4):296-302.
    View in: PubMed
  252. Brambilla P, Soloff PH, Sala M, Nicoletti MA, Keshavan MS, Soares JC. Anatomical MRI study of borderline personality disorder patients. Psychiatry Res. 2004 Jul 30; 131(2):125-33.
    View in: PubMed
  253. Prasad KM, Rohm BR, Keshavan MS. Parahippocampal gyrus in first episode psychotic disorders: a structural magnetic resonance imaging study. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jul; 28(4):651-8.
    View in: PubMed
  254. Shad MU, Muddasani S, Prasad K, Sweeney JA, Keshavan MS. Insight and prefrontal cortex in first-episode Schizophrenia. Neuroimage. 2004 Jul; 22(3):1315-20.
    View in: PubMed
  255. Gangadhar BN, Jayakumar PN, Subbakrishna DK, Janakiramaiah N, Keshavan MS. Basal ganglia high-energy phosphate metabolism in neuroleptic-naive patients with schizophrenia: a 31-phosphorus magnetic resonance spectroscopic study. Am J Psychiatry. 2004 Jul; 161(7):1304-6.
    View in: PubMed
  256. Chen HH, Nicoletti MA, Hatch JP, Sassi RB, Axelson D, Brambilla P, Monkul ES, Keshavan MS, Ryan ND, Birmaher B, Soares JC. Abnormal left superior temporal gyrus volumes in children and adolescents with bipolar disorder: a magnetic resonance imaging study. Neurosci Lett. 2004 Jun 3; 363(1):65-8.
    View in: PubMed
  257. Hill SK, Keshavan MS, Thase ME, Sweeney JA. Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression. Am J Psychiatry. 2004 Jun; 161(6):996-1003.
    View in: PubMed
  258. Hill SK, Beers SR, Kmiec JA, Keshavan MS, Sweeney JA. Impairment of verbal memory and learning in antipsychotic-naïve patients with first-episode schizophrenia. Schizophr Res. 2004 Jun 1; 68(2-3):127-36.
    View in: PubMed
  259. Hill SK, Schuepbach D, Herbener ES, Keshavan MS, Sweeney JA. Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naïve patients with schizophrenia. Schizophr Res. 2004 May 1; 68(1):49-63.
    View in: PubMed
  260. Diwadkar VA, DeBellis MD, Sweeney JA, Pettegrew JW, Keshavan MS. Abnormalities in MRI-measured signal intensity in the corpus callosum in schizophrenia. Schizophr Res. 2004 Apr 1; 67(2-3):277-82.
    View in: PubMed
  261. Shashi V, Muddasani S, Santos CC, Berry MN, Kwapil TR, Lewandowski E, Keshavan MS. Abnormalities of the corpus callosum in nonpsychotic children with chromosome 22q11 deletion syndrome. Neuroimage. 2004 Apr; 21(4):1399-406.
    View in: PubMed
  262. Lacerda AL, Keshavan MS, Hardan AY, Yorbik O, Brambilla P, Sassi RB, Nicoletti M, Mallinger AG, Frank E, Kupfer DJ, Soares JC. Anatomic evaluation of the orbitofrontal cortex in major depressive disorder. Biol Psychiatry. 2004 Feb 15; 55(4):353-8.
    View in: PubMed
  263. Brambilla P, Nicoletti M, Sassi RB, Mallinger AG, Frank E, Keshavan MS, Soares JC. Corpus callosum signal intensity in patients with bipolar and unipolar disorder. J Neurol Neurosurg Psychiatry. 2004 Feb; 75(2):221-5.
    View in: PubMed
  264. Chen HH, Nicoletti M, Sanches M, Hatch JP, Sassi RB, Axelson D, Brambilla P, Keshavan MS, Ryan N, Birmaher B, Soares JC. Normal pituitary volumes in children and adolescents with bipolar disorder: a magnetic resonance imaging study. Depress Anxiety. 2004; 20(4):182-6.
    View in: PubMed
  265. Sanders RD, Schuepbach D, Goldstein G, Haas GL, Sweeney JA, Keshavan MS. Relationships between cognitive and neurological performance in neuroleptic-naïve psychosis. J Neuropsychiatry Clin Neurosci. 2004; 16(4):480-7.
    View in: PubMed
  266. Schuepbach D, Hill SK, Sanders RD, Hell D, Keshavan MS, Sweeney JA. Early treatment-induced improvement of negative symptoms predicts cognitive functioning in treatment-naive first episode schizophrenia: a 2-year followup. Schizophr Bull. 2004; 30(4):837-48.
    View in: PubMed
  267. Reddy RD, Keshavan MS, Yao JK. Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline. Schizophr Bull. 2004; 30(4):901-11.
    View in: PubMed
  268. Gilbert AR, Montrose D, Sahni S, Diwadkar VA, Keshavan MS. Obstetric complications correlate with neurobehavioral and brain structural alterations in young relatives at risk for schizophrenia. Ann N Y Acad Sci. 2003 Dec; 1008:269-75.
    View in: PubMed
  269. Reddy R, Keshavan MS. Phosphorus magnetic resonance spectroscopy: its utility in examining the membrane hypothesis of schizophrenia. Prostaglandins Leukot Essent Fatty Acids. 2003 Dec; 69(6):401-5.
    View in: PubMed
  270. Brambilla P, Nicoletti MA, Sassi RB, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC. Magnetic resonance imaging study of corpus callosum abnormalities in patients with bipolar disorder. Biol Psychiatry. 2003 Dec 1; 54(11):1294-7.
    View in: PubMed
  271. Sassi RB, Brambilla P, Nicoletti M, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC. White matter hyperintensities in bipolar and unipolar patients with relatively mild-to-moderate illness severity. J Affect Disord. 2003 Dec; 77(3):237-45.
    View in: PubMed
  272. Lacerda AL, Nicoletti MA, Brambilla P, Sassi RB, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC. Anatomical MRI study of basal ganglia in major depressive disorder. Psychiatry Res. 2003 Nov 30; 124(3):129-40.
    View in: PubMed
  273. Jayakumar PN, Gangadhar BN, Subbakrishna DK, Janakiramaiah N, Srinivas JS, Keshavan MS. Membrane phospholipid abnormalities of basal ganglia in never-treated schizophrenia: a 31P magnetic resonance spectroscopy study. Biol Psychiatry. 2003 Aug 15; 54(4):491-4.
    View in: PubMed
  274. Venkatasubramanian G, Latha V, Gangadhar BN, Janakiramaiah N, Subbakrishna DK, Jayakumar PN, Keshavan MS. Neurological soft signs in never-treated schizophrenia. Acta Psychiatr Scand. 2003 Aug; 108(2):144-6.
    View in: PubMed
  275. Reddy R, Keshavan M, Yao JK. Reduced plasma antioxidants in first-episode patients with schizophrenia. Schizophr Res. 2003 Aug 1; 62(3):205-12.
    View in: PubMed
  276. Lacerda AL, Hardan AY, Yorbik O, Keshavan MS. Measurement of the orbitofrontal cortex: a validation study of a new method. Neuroimage. 2003 Jul; 19(3):665-73.
    View in: PubMed
  277. Keshavan MS, Sanders RD, Sweeney JA, Diwadkar VA, Goldstein G, Pettegrew JW, Schooler NR. Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses. Am J Psychiatry. 2003 Jul; 160(7):1298-304.
    View in: PubMed
  278. Brambilla P, Harenski K, Nicoletti M, Sassi RB, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC. MRI investigation of temporal lobe structures in bipolar patients. J Psychiatr Res. 2003 Jul-Aug; 37(4):287-95.
    View in: PubMed
  279. Lacerda AL, Dalgalarrondo P, Caetano D, Haas GL, Camargo EE, Keshavan MS. Neuropsychological performance and regional cerebral blood flow in obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2003 Jun; 27(4):657-65.
    View in: PubMed
  280. Venkatasubramanian G, Jayakumar PN, Gangadhar BN, Janakiramaiah N, Subbakrishna DK, Keshavan MS. Measuring the corpus callosum in schizophrenia: a technique with neuroanatomical and cytoarchtectural basis. Neurol India. 2003 Jun; 51(2):189-92.
    View in: PubMed
  281. Hardan AY, Kilpatrick M, Keshavan MS, Minshew NJ. Motor performance and anatomic magnetic resonance imaging (MRI) of the basal ganglia in autism. J Child Neurol. 2003 May; 18(5):317-24.
    View in: PubMed
  282. Venkatasubramanian G, Gangadhar BN, Jayakumar PN, Janakiramaiah N, Keshavan MS. Reduced Caudate Volume in Never-Treated Schizophrenia : Evidence for Neuro developmental Etiopathogenesis. Indian J Psychiatry. 2003 Apr; 45(2):20-6.
    View in: PubMed
  283. Keshavan MS, Stanley JA, Montrose DM, Minshew NJ, Pettegrew JW. Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder: an in vivo 31P MRS study. Mol Psychiatry. 2003 Mar; 8(3):316-23, 251.
    View in: PubMed
  284. Keshavan MS, Haas G, Miewald J, Montrose DM, Reddy R, Schooler NR, Sweeney JA. Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses. Schizophr Bull. 2003; 29(4):757-69.
    View in: PubMed
  285. De Bellis MD, Keshavan MS. Sex differences in brain maturation in maltreatment-related pediatric posttraumatic stress disorder. Neurosci Biobehav Rev. 2003 Jan-Mar; 27(1-2):103-17.
    View in: PubMed
  286. Seidman LJ, Pantelis C, Keshavan MS, Faraone SV, Goldstein JM, Horton NJ, Makris N, Falkai P, Caviness VS, Tsuang MT. A review and new report of medial temporal lobe dysfunction as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric family study of the parahippocampal gyrus. Schizophr Bull. 2003; 29(4):803-30.
    View in: PubMed
  287. Cannon TD, van Erp TG, Bearden CE, Loewy R, Thompson P, Toga AW, Huttunen MO, Keshavan MS, Seidman LJ, Tsuang MT. Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions. Schizophr Bull. 2003; 29(4):653-69.
    View in: PubMed
  288. Keshavan MS, Sujata M, Mehra A, Montrose DM, Sweeney JA. Psychosis proneness and ADHD in young relatives of schizophrenia patients. Schizophr Res. 2003 Jan 1; 59(1):85-92.
    View in: PubMed
  289. Keshavan MS, Dick E, Mankowski I, Harenski K, Montrose DM, Diwadkar V, DeBellis M. Decreased left amygdala and hippocampal volumes in young offspring at risk for schizophrenia. Schizophr Res. 2002 Dec 1; 58(2-3):173-83.
    View in: PubMed
  290. De Bellis MD, Keshavan MS, Shifflett H, Iyengar S, Beers SR, Hall J, Moritz G. Brain structures in pediatric maltreatment-related posttraumatic stress disorder: a sociodemographically matched study. Biol Psychiatry. 2002 Dec 1; 52(11):1066-78.
    View in: PubMed
  291. Brambilla P, Nicoletti MA, Harenski K, Sassi RB, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC. Anatomical MRI study of subgenual prefrontal cortex in bipolar and unipolar subjects. Neuropsychopharmacology. 2002 Nov; 27(5):792-9.
    View in: PubMed
  292. Yao Jk, Stanley JA, Reddy RD, Keshavan MS, Pettegrew JW. Correlations between peripheral polyunsaturated fatty acid content and in vivo membrane phospholipid metabolites. Biol Psychiatry. 2002 Oct 15; 52(8):823-30.
    View in: PubMed
  293. Keshavan MS, Diwadkar VA, Spencer SM, Harenski KA, Luna B, Sweeney JA. A preliminary functional magnetic resonance imaging study in offspring of schizophrenic parents. Prog Neuropsychopharmacol Biol Psychiatry. 2002 Oct; 26(6):1143-9.
    View in: PubMed
  294. Sassi RB, Nicoletti M, Brambilla P, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC. Increased gray matter volume in lithium-treated bipolar disorder patients. Neurosci Lett. 2002 Aug 30; 329(2):243-5.
    View in: PubMed
  295. Diwadkar VA, Keshavan MS. Newer techniques in magnetic resonance imaging and their potential for neuropsychiatric research. J Psychosom Res. 2002 Aug; 53(2):677-85.
    View in: PubMed
  296. Keshavan MS, Diwadkar VA, Harenski K, Rosenberg DR, Sweeney JA, Pettegrew JW. Abnormalities of the corpus callosum in first episode, treatment naive schizophrenia. J Neurol Neurosurg Psychiatry. 2002 Jun; 72(6):757-60.
    View in: PubMed
  297. De Bellis MD, Keshavan MS, Frustaci K, Shifflett H, Iyengar S, Beers SR, Hall J. Superior temporal gyrus volumes in maltreated children and adolescents with PTSD. Biol Psychiatry. 2002 Apr 1; 51(7):544-52.
    View in: PubMed
  298. Brambilla P, Stanley JA, Nicoletti M, Harenski K, Wells KF, Mallinger AG, Keshavan MS, Soares JC. 1H MRS brain measures and acute lorazepam administration in healthy human subjects. Neuropsychopharmacology. 2002 Apr; 26(4):546-51.
    View in: PubMed
  299. De Bellis MD, Keshavan MS, Shifflett H, Iyengar S, Dahl RE, Axelson DA, Birmaher B, Hall J, Moritz G, Ryan ND. Superior temporal gyrus volumes in pediatric generalized anxiety disorder. Biol Psychiatry. 2002 Apr 1; 51(7):553-62.
    View in: PubMed
  300. Keshavan MS, Diwadkar VA, DeBellis M, Dick E, Kotwal R, Rosenberg DR, Sweeney JA, Minshew N, Pettegrew JW. Development of the corpus callosum in childhood, adolescence and early adulthood. Life Sci. 2002 Mar 8; 70(16):1909-22.
    View in: PubMed
  301. Keshavan MS, Jayakumar PN, Diwadkar VA, Singh A. Cavum septi pellucidi in first-episode patients and young relatives at risk for schizophrenia. CNS Spectr. 2002 Feb; 7(2):155-8.
    View in: PubMed
  302. Schuepbach D, Keshavan MS, Kmiec JA, Sweeney JA. Negative symptom resolution and improvements in specific cognitive deficits after acute treatment in first-episode schizophrenia. Schizophr Res. 2002 Jan 15; 53(3):249-61.
    View in: PubMed
  303. Sanders RD, Keshavan MS. Physical and neurologic examinations in neuropsychiatry. Semin Clin Neuropsychiatry. 2002 Jan; 7(1):18-29.
    View in: PubMed
  304. Caetano SC, Sassi R, Brambilla P, Harenski K, Nicoletti M, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC. MRI study of thalamic volumes in bipolar and unipolar patients and healthy individuals. Psychiatry Res. 2001 Dec 30; 108(3):161-8.
    View in: PubMed
  305. Diwadkar VA, Sweeney JA, Boarts D, Montrose DM, Keshavan MS. Oculomotor delayed response abnormalities in young offspring and siblings at risk for schizophrenia. CNS Spectr. 2001 Nov; 6(11):899-903.
    View in: PubMed
  306. Brambilla P, Harenski K, Nicoletti M, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC. MRI study of posterior fossa structures and brain ventricles in bipolar patients. J Psychiatr Res. 2001 Nov-Dec; 35(6):313-22.
    View in: PubMed
  307. Sassi RB, Nicoletti M, Brambilla P, Harenski K, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC. Decreased pituitary volume in patients with bipolar disorder. Biol Psychiatry. 2001 Aug 15; 50(4):271-80.
    View in: PubMed
  308. Hill SY, De Bellis MD, Keshavan MS, Lowers L, Shen S, Hall J, Pitts T. Right amygdala volume in adolescent and young adult offspring from families at high risk for developing alcoholism. Biol Psychiatry. 2001 Jun 1; 49(11):894-905.
    View in: PubMed
  309. De Bellis MD, Keshavan MS, Beers SR, Hall J, Frustaci K, Masalehdan A, Noll J, Boring AM. Sex differences in brain maturation during childhood and adolescence. Cereb Cortex. 2001 Jun; 11(6):552-7.
    View in: PubMed
  310. Hardan AY, Minshew NJ, Harenski K, Keshavan MS. Posterior fossa magnetic resonance imaging in autism. J Am Acad Child Adolesc Psychiatry. 2001 Jun; 40(6):666-72.
    View in: PubMed
  311. Hardan AY, Minshew NJ, Mallikarjuhn M, Keshavan MS. Brain volume in autism. J Child Neurol. 2001 Jun; 16(6):421-4.
    View in: PubMed
  312. Luna B, Thulborn KR, Munoz DP, Merriam EP, Garver KE, Minshew NJ, Keshavan MS, Genovese CR, Eddy WF, Sweeney JA. Maturation of widely distributed brain function subserves cognitive development. Neuroimage. 2001 May; 13(5):786-93.
    View in: PubMed
  313. Brambilla P, Harenski K, Nicoletti MA, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC. Anatomical MRI study of basal ganglia in bipolar disorder patients. Psychiatry Res. 2001 Apr 10; 106(2):65-80.
    View in: PubMed
  314. Gilbert AR, Rosenberg DR, Harenski K, Spencer S, Sweeney JA, Keshavan MS. Thalamic volumes in patients with first-episode schizophrenia. Am J Psychiatry. 2001 Apr; 158(4):618-24.
    View in: PubMed
  315. Soares JC, Boada F, Spencer S, Mallinger AG, Dippold CS, Wells KF, Frank E, Keshavan MS, Gershon S, Kupfer DJ. Brain lithium concentrations in bipolar disorder patients: preliminary (7)Li magnetic resonance studies at 3 T. Biol Psychiatry. 2001 Mar 1; 49(5):437-43.
    View in: PubMed
  316. Brambilla P, Harenski K, Nicoletti M, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC. Differential effects of age on brain gray matter in bipolar patients and healthy individuals. Neuropsychobiology. 2001; 43(4):242-7.
    View in: PubMed
  317. De Bellis MD, Keshavan MS, Harenski KA. Anterior cingulate N-acetylaspartate/creatine ratios during clonidine treatment in a maltreated child with posttraumatic stress disorder. J Child Adolesc Psychopharmacol. 2001; 11(3):311-6.
    View in: PubMed
  318. Hardan AY, Minshew NJ, Keshavan MS. Corpus callosum size in autism. Neurology. 2000 Oct 10; 55(7):1033-6.
    View in: PubMed
  319. Sanders RD, Keshavan MS, Forman SD, Pieri JN, McLaughlin N, Allen DN, van Kammen DP, Goldstein G. Factor structure of neurologic examination abnormalities in unmedicated schizophrenia. Psychiatry Res. 2000 Sep 11; 95(3):237-43.
    View in: PubMed
  320. Stanley JA, Pettegrew JW, Keshavan MS. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part I. Biol Psychiatry. 2000 Sep 1; 48(5):357-68.
    View in: PubMed
  321. Keshavan MS, Stanley JA, Pettegrew JW. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part II. Biol Psychiatry. 2000 Sep 1; 48(5):369-80.
    View in: PubMed
  322. Rosenberg DR, MacMaster FP, Keshavan MS, Fitzgerald KD, Stewart CM, Moore GJ. Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry. 2000 Sep; 39(9):1096-103.
    View in: PubMed
  323. Allen DN, Goldstein G, Forman SD, Keshavan MS, van Kammen DP, Sanders RD. Neurologic examination abnormalities in schizophrenia with and without a history of alcoholism. Neuropsychiatry Neuropsychol Behav Neurol. 2000 Jul; 13(3):184-7.
    View in: PubMed
  324. De Bellis MD, Keshavan MS, Spencer S, Hall J. N-Acetylaspartate concentration in the anterior cingulate of maltreated children and adolescents with PTSD. Am J Psychiatry. 2000 Jul; 157(7):1175-7.
    View in: PubMed
  325. Gilbert AR, Moore GJ, Keshavan MS, Paulson LA, Narula V, Mac Master FP, Stewart CM, Rosenberg DR. Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine. Arch Gen Psychiatry. 2000 May; 57(5):449-56.
    View in: PubMed
  326. De Bellis MD, Clark DB, Beers SR, Soloff PH, Boring AM, Hall J, Kersh A, Keshavan MS. Hippocampal volume in adolescent-onset alcohol use disorders. Am J Psychiatry. 2000 May; 157(5):737-44.
    View in: PubMed
  327. Soares JC, Boada F, Keshavan MS. Brain lithium measurements with (7)Li magnetic resonance spectroscopy (MRS): a literature review. Eur Neuropsychopharmacol. 2000 May; 10(3):151-8.
    View in: PubMed
  328. Keshavan MS. Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. J Psychiatr Res. 1999 Nov-Dec; 33(6):513-21.
    View in: PubMed
  329. Sweeney JA, Luna B, Haas GL, Keshavan MS, Mann JJ, Thase ME. Pursuit tracking impairments in schizophrenia and mood disorders: step-ramp studies with unmedicated patients. Biol Psychiatry. 1999 Sep 1; 46(5):671-80.
    View in: PubMed
  330. Keshavan MS, Carter C, Haas G, Schooler NR. Schizophreniform disorder: exception proves the rule. Am J Psychiatry. 1999 Jun; 156(6):971-2.
    View in: PubMed
  331. DeQuardo JR, Keshavan MS, Bookstein FL, Bagwell WW, Green WD, Sweeney JA, Haas GL, Tandon R, Schooler NR, Pettegrew JW. Landmark-based morphometric analysis of first-episode schizophrenia. Biol Psychiatry. 1999 May 15; 45(10):1321-8.
    View in: PubMed
  332. De Bellis MD, Keshavan MS, Clark DB, Casey BJ, Giedd JN, Boring AM, Frustaci K, Ryan ND. A.E. Bennett Research Award. Developmental traumatology. Part II: Brain development. Biol Psychiatry. 1999 May 15; 45(10):1271-84.
    View in: PubMed
  333. De Bellis MD, Baum AS, Birmaher B, Keshavan MS, Eccard CH, Boring AM, Jenkins FJ, Ryan ND. A.E. Bennett Research Award. Developmental traumatology. Part I: Biological stress systems. Biol Psychiatry. 1999 May 15; 45(10):1259-70.
    View in: PubMed
  334. Keshavan MS, Rosenberg DR. New trends in developmental neuroimaging in psychiatry. Prog Neuropsychopharmacol Biol Psychiatry. 1999 May; 23(4):557-60.
    View in: PubMed
  335. Merriam EP, Thase ME, Haas GL, Keshavan MS, Sweeney JA. Prefrontal cortical dysfunction in depression determined by Wisconsin Card Sorting Test performance. Am J Psychiatry. 1999 May; 156(5):780-2.
    View in: PubMed
  336. Mac Master FP, Keshavan MS, Dick EL, Rosenberg DR. Corpus callosal signal intensity in treatment-naive pediatric obsessive compulsive disorders. Prog Neuropsychopharmacol Biol Psychiatry. 1999 May; 23(4):601-12.
    View in: PubMed
  337. Mamo DC, Sweet RA, Keshavan MS. Managing antipsychotic-induced parkinsonism. Drug Saf. 1999 Mar; 20(3):269-75.
    View in: PubMed
  338. Keshavan MS, Hogarty GE. Brain maturational processes and delayed onset in schizophrenia. Dev Psychopathol. 1999; 11(3):525-43.
    View in: PubMed
  339. Sweeney JA, Luna B, Srinivasagam NM, Keshavan MS, Schooler NR, Haas GL, Carl JR. Eye tracking abnormalities in schizophrenia: evidence for dysfunction in the frontal eye fields. Biol Psychiatry. 1998 Oct 15; 44(8):698-708.
    View in: PubMed
  340. Keshavan MS, Rosenberg D, Sweeney JA, Pettegrew JW. Decreased caudate volume in neuroleptic-naive psychotic patients. Am J Psychiatry. 1998 Jun; 155(6):774-8.
    View in: PubMed
  341. Keshavan MS, Reynolds CF, Miewald MJ, Montrose DM, Sweeney JA, Vasko RC, Kupfer DJ. Delta sleep deficits in schizophrenia: evidence from automated analyses of sleep data. Arch Gen Psychiatry. 1998 May; 55(5):443-8.
    View in: PubMed
  342. Rosenberg DR, Keshavan MS. A.E. Bennett Research Award. Toward a neurodevelopmental model of of obsessive--compulsive disorder. Biol Psychiatry. 1998 May 1; 43(9):623-40.
    View in: PubMed
  343. Keshavan MS, Haas GL, Kahn CE, Aguilar E, Dick EL, Schooler NR, Sweeney JA, Pettegrew JW. Superior temporal gyrus and the course of early schizophrenia: progressive, static, or reversible? J Psychiatr Res. 1998 May-Aug; 32(3-4):161-7.
    View in: PubMed
  344. McClure RJ, Keshavan MS, Pettegrew JW. Chemical and physiologic brain imaging in schizophrenia. Psychiatr Clin North Am. 1998 Mar; 21(1):93-122.
    View in: PubMed
  345. Sanders RD, Forman SD, Pierri JN, Baker RW, Kelley ME, Van Kammen DP, Keshavan MS. Inter-rater reliability of the neurological examination in schizophrenia. Schizophr Res. 1998 Feb 9; 29(3):287-92.
    View in: PubMed
  346. Saba PR, Dastur K, Keshavan MS, Katerji MA. Obsessive-compulsive disorder, Tourette's syndrome, and basal ganglia pathology on MRI. J Neuropsychiatry Clin Neurosci. 1998; 10(1):116-7.
    View in: PubMed
  347. Figueroa Y, Rosenberg DR, Birmaher B, Keshavan MS. Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents. J Child Adolesc Psychopharmacol. 1998; 8(1):61-7.
    View in: PubMed
  348. Keshavan MS, Schooler NR, Sweeney JA, Haas GL, Pettegrew JW. Research and treatment strategies in first-episode psychoses. The Pittsburgh experience. Br J Psychiatry Suppl. 1998; 172(33):60-5.
    View in: PubMed
  349. Sanders RD, Keshavan MS. The neurologic examination in adult psychiatry: from soft signs to hard science. J Neuropsychiatry Clin Neurosci. 1998; 10(4):395-404.
    View in: PubMed
  350. Gracia Marco R, Aguilar Garcia-Iturrospe EJ, Fernandez Lopez L, Cejas Mendez MR, Herreros Rodriguez O, Diaz Ramirez A, Hernandez Martinez J, Keshavan MS. Hypofrontality in schizophrenia: influence of normalization methods. Prog Neuropsychopharmacol Biol Psychiatry. 1997 Nov; 21(8):1239-56.
    View in: PubMed
  351. Rosenberg DR, Keshavan MS, Dick EL, Bagwell WW, MacMaster FP, Birmaher B. Corpus callosal morphology in treatment-naive pediatric obsessive compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 1997 Nov; 21(8):1269-83.
    View in: PubMed
  352. Keshavan MS, Montrose DM, Pierri JN, Dick EL, Rosenberg D, Talagala L, Sweeney JA. Magnetic resonance imaging and spectroscopy in offspring at risk for schizophrenia: preliminary studies. Prog Neuropsychopharmacol Biol Psychiatry. 1997 Nov; 21(8):1285-95.
    View in: PubMed
  353. Keshavan MS, Krishnan RR. New frontiers in psychiatric neuroimaging. Prog Neuropsychopharmacol Biol Psychiatry. 1997 Nov; 21(8):1181-3.
    View in: PubMed
  354. Rosenberg DR, Keshavan MS, O'Hearn KM, Dick EL, Bagwell WW, Seymour AB, Montrose DM, Pierri JN, Birmaher B. Frontostriatal measurement in treatment-naive children with obsessive-compulsive disorder. Arch Gen Psychiatry. 1997 Sep; 54(9):824-30.
    View in: PubMed
  355. Aguilar EJ, Haas G, Manzanera FJ, Hernández J, Gracia R, Rodado MJ, Keshavan MS. Hopelessness and first-episode psychosis: a longitudinal study. Acta Psychiatr Scand. 1997 Jul; 96(1):25-30.
    View in: PubMed
  356. Sweeney JA, Bauer KS, Keshavan MS, Haas GL, Schooler NR, Kroboth PD. Adverse effects of risperidone on eye movement activity: a comparison of risperidone and haloperidol in antipsychotic-naive schizophrenic patients. Neuropsychopharmacology. 1997 Mar; 16(3):217-28.
    View in: PubMed
  357. Rosenberg DR, Sweeney JA, Squires-Wheeler E, Keshavan MS, Cornblatt BA, Erlenmeyer-Kimling L. Eye-tracking dysfunction in offspring from the New York High-Risk Project: diagnostic specificity and the role of attention. Psychiatry Res. 1997 Feb 7; 66(2-3):121-30.
    View in: PubMed
  358. Saba PR, Keshavan MS. Musical hallucinations and musical imagery: prevalence and phenomenology in schizophrenic inpatients. Psychopathology. 1997; 30(4):185-90.
    View in: PubMed
  359. Keshavan MS, Mulsant BH, Sweet RA, Pasternak R, Zubenko GS, Krishnan RR. MRI changes in schizophrenia in late life: a preliminary controlled study. Psychiatry Res. 1996 Mar 29; 60(2-3):117-23.
    View in: PubMed
  360. Keshavan MS, Reynolds CF, Miewald JM, Montrose DM. A longitudinal study of EEG sleep in schizophrenia. Psychiatry Res. 1996 Jan 31; 59(3):203-11.
    View in: PubMed
  361. Soares JC, Krishnan KR, Keshavan MS. Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders. Depression. 1996; 4(1):14-30.
    View in: PubMed
  362. Quintana H, Keshavan M. Case study: risperidone in children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry. 1995 Oct; 34(10):1292-6.
    View in: PubMed
  363. Keshavan MS, Pettegrew JW, Reynolds CF, Panchalingam KS, Montrose D, Miewald J, Kupfer DJ. Biological correlates of slow wave sleep deficits in functional psychoses: 31P-magnetic resonance spectroscopy. Psychiatry Res. 1995 Jul 28; 57(2):91-100.
    View in: PubMed
  364. Keshavan MS, Miewald J, Haas G, Sweeney J, Ganguli R, Reynolds CF. Slow-wave sleep and symptomatology in schizophrenia and related psychotic disorders. J Psychiatr Res. 1995 Jul-Aug; 29(4):303-14.
    View in: PubMed
  365. Keshavan MS, Anderson S, Beckwith C, Nash K, Pettegrew JW, Krishnan KR. A comparison of stereology and segmentation techniques for volumetric measurements of lateral ventricles in magnetic resonance imaging. Psychiatry Res. 1995 May 31; 61(1):53-60.
    View in: PubMed
  366. Keshavan MS, Reynolds CF, Haas G, Miewald JM, Montrose DM. Sleep EEG changes in psychotic disorders: gender and age effects. Neuropsychobiology. 1995; 32(1):1-8.
    View in: PubMed
  367. Aguilar EJ, Keshavan MS, Martínez-Quiles MD, Hernández J, Gómez-Beneyto M, Schooler NR. Predictors of acute dystonia in first-episode psychotic patients. Am J Psychiatry. 1994 Dec; 151(12):1819-21.
    View in: PubMed
  368. Keshavan MS, Bagwell WW, Haas GL, Sweeney JA, Schooler NR, Pettegrew JW. Changes in caudate volume with neuroleptic treatment. Lancet. 1994 Nov 19; 344(8934):1434.
    View in: PubMed
  369. Diehl DJ, Keshavan MS, Kanal E, Nebes RD, Nichols TE, Gillen JS. Post-ECT increases in MRI regional T2 relaxation times and their relationship to cognitive side effects: a pilot study. Psychiatry Res. 1994 Nov; 54(2):177-84.
    View in: PubMed
  370. Fabrega H, Ulrich R, Keshavan M. Gender differences in how medical students learn to rate psychopathology. J Nerv Ment Dis. 1994 Aug; 182(8):471-5.
    View in: PubMed
  371. Sanders RD, Keshavan MS, Schooler NR. Neurological examination abnormalities in neuroleptic-naive patients with first-break schizophrenia: preliminary results. Am J Psychiatry. 1994 Aug; 151(8):1231-3.
    View in: PubMed
  372. Keshavan MS, Anderson S, Pettegrew JW. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J Psychiatr Res. 1994 May-Jun; 28(3):239-65.
    View in: PubMed
  373. Houlihan DJ, Flaum M, Arnold SE, Keshavan M, Alliger R. Further evidence for olfactory identification deficits in schizophrenia. Schizophr Res. 1994 May; 12(2):179-82.
    View in: PubMed
  374. Keshavan MS, Reynolds CF, Montrose D, Miewald J, Downs C, Sabo EM. Sleep and suicidality in psychotic patients. Acta Psychiatr Scand. 1994 Feb; 89(2):122-5.
    View in: PubMed
  375. Keshavan MS, Stecker J, Kambhampati RK. Creatine kinase elevations with clozapine. Br J Psychiatry. 1994 Jan; 164(1):118-20.
    View in: PubMed
  376. Keshavan MS, Tandon R. Sleep abnormalities in schizophrenia: pathophysiological significance. Psychol Med. 1993 Nov; 23(4):831-5.
    View in: PubMed
  377. Keshavan MS, Sanders RD, Pettegrew JW, Dombrowsky SM, Panchalingam KS. Frontal lobe metabolism and cerebral morphology in schizophrenia: 31P MRS and MRI studies. Schizophr Res. 1993 Oct; 10(3):241-6.
    View in: PubMed
  378. Keshavan MS, Mallinger AG, Pettegrew JW, Dippold C. Erythrocyte membrane phospholipids in psychotic patients. Psychiatry Res. 1993 Oct; 49(1):89-95.
    View in: PubMed
  379. Keshavan M. Muscarinic effects of clozapine and negative symptoms. Arch Gen Psychiatry. 1993 Oct; 50(10):835.
    View in: PubMed
  380. Mulsant BH, Stergiou A, Keshavan MS, Sweet RA, Rifai AH, Pasternak R, Zubenko GS. Schizophrenia in late life: elderly patients admitted to an acute care psychiatric hospital. Schizophr Bull. 1993; 19(4):709-21.
    View in: PubMed
  381. Pettegrew JW, Keshavan MS, Minshew NJ. 31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia. Schizophr Bull. 1993; 19(1):35-53.
    View in: PubMed
  382. Keshavan MS, Mahadik SP, Reynolds CF, Mukerjee S, Korenovsky A, Houck P, Jarrett DB. Plasma cholinesterase isozymes and REM latency in schizophrenia. Psychiatry Res. 1992 Jul; 43(1):23-9.
    View in: PubMed
  383. Keshavan MS, Schooler NR. First-episode studies in schizophrenia: criteria and characterization. Schizophr Bull. 1992; 18(3):491-513.
    View in: PubMed
  384. Keshavan MS, Reynolds CF, Montrose D, Miewald J, Kupfer DJ. Trait-like abnormalities in the sleep of patients with psychoses. Clin Neuropharmacol. 1992; 15 Suppl 1 Pt A:297A-298A.
    View in: PubMed
  385. Keshavan MS, Reynolds CF, Ganguli R, Brar J, Houck P. Electroencephalographic sleep and cerebral morphology in functional psychoses: a preliminary study with computed tomography. Psychiatry Res. 1991 Dec; 39(3):293-301.
    View in: PubMed
  386. Keshavan MS, Pettegrew JW, Panchalingam KS, Kaplan D, Bozik E. Phosphorus 31 magnetic resonance spectroscopy detects altered brain metabolism before onset of schizophrenia. Arch Gen Psychiatry. 1991 Dec; 48(12):1112-3.
    View in: PubMed
  387. Chengappa KN, Carpenter AB, Keshavan MS, Yang ZW, Kelly RH, Rabin BS, Ganguli R. Elevated IGG and IGM anticardiolipin antibodies in a subgroup of medicated and unmedicated schizophrenic patients. Biol Psychiatry. 1991 Oct 1; 30(7):731-5.
    View in: PubMed
  388. Keshavan MS, Kapur S, Pettegrew JW. Magnetic resonance spectroscopy in psychiatry: potential, pitfalls, and promise. Am J Psychiatry. 1991 Aug; 148(8):976-85.
    View in: PubMed
  389. Pettegrew JW, Keshavan MS, Panchalingam K, Strychor S, Kaplan DB, Tretta MG, Allen M. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Arch Gen Psychiatry. 1991 Jun; 48(6):563-8.
    View in: PubMed
  390. Caldwell C, Keshavan MS. Schizophrenia with secondary transsexualism. Can J Psychiatry. 1991 May; 36(4):300-1.
    View in: PubMed
  391. Dassori AM, Mezzich JE, Keshavan M. Suicidal indicators in schizophrenia. Acta Psychiatr Scand. 1990 May; 81(5):409-13.
    View in: PubMed
  392. Joyce EM, Moodley P, Keshavan MS, Lader MH. Failure of clonidine treatment in benzodiazepine withdrawal. J Psychopharmacol. 1990 Jan; 4(1):42-5.
    View in: PubMed
  393. Keshavan MS, Reynolds CF, Kupfer DJ. Electroencephalographic sleep in schizophrenia: a critical review. Compr Psychiatry. 1990 Jan-Feb; 31(1):34-47.
    View in: PubMed
  394. Yeragani VK, Pohl R, Balon R, Kulkarni A, Keshavan M. Low serum iron levels and tricyclic antidepressant-induced jitteriness. J Clin Psychopharmacol. 1989 Dec; 9(6):447-8.
    View in: PubMed
  395. Keshavan MS, Brar J, Ganguli R, Jarrett D. DST and schizophrenic symptomatology. Biol Psychiatry. 1989 Dec; 26(8):856-8.
    View in: PubMed
  396. Abramson L, Keshavan MS, Sitaram N. Elevated sleep and waking heart rates in anxious depressions. Biol Psychiatry. 1989 Sep; 26(5):496-9.
    View in: PubMed
  397. Chengappa KN, Steingard S, Brar JS, Keshavan MS. Delusions of pregnancy in men. Br J Psychiatry. 1989 Sep; 155:422-4.
    View in: PubMed
  398. Keshavan MS, Kambhampati RK. Prolonged fever without extrapyramidal symptoms during neuroleptic treatment. J Clin Psychopharmacol. 1989 Jun; 9(3):230-1.
    View in: PubMed
  399. Keshavan MS, Narayanan HS, Gangadhar BN. 'Bhanamati' sorcery and psychopathology in south India. A clinical study. Br J Psychiatry. 1989 Feb; 154:218-20.
    View in: PubMed
  400. Vogel-Scibilia SE, Mulsant BH, Keshavan MS. HIV infection presenting as psychosis: a critique. Acta Psychiatr Scand. 1988 Nov; 78(5):652-6.
    View in: PubMed
  401. Keshavan MS. The ear wigglers: tics of the ear in 10 patients. Am J Psychiatry. 1988 Nov; 145(11):1462-3.
    View in: PubMed
  402. Keshavan MS, Moodley P, Eales M, Joyce E, Yeragani VK. Delusional depression following benzodiazepine withdrawal. Can J Psychiatry. 1988 Oct; 33(7):626-7.
    View in: PubMed
  403. Keshavan MS, Kahn EM, Brar JS. Musical hallucinations following removal of a right frontal meningioma. J Neurol Neurosurg Psychiatry. 1988 Sep; 51(9):1235-6.
    View in: PubMed
  404. Adair DK, Keshavan MS. The Charles Bonnet syndrome and grief reaction. Am J Psychiatry. 1988 Jul; 145(7):895-6.
    View in: PubMed
  405. Keshavan M, Dubé S, Grabowski J, Sitaram N. Cholinergic REM sleep induction by arecoline in normal subjects: relation to thyroid function. Psychiatry Res. 1988 Jun; 24(3):333-6.
    View in: PubMed
  406. Keshavan MS, Toone BS. Heterogeneity in sporadic schizophrenia. Br J Psychiatry. 1988 Apr; 152:573-5.
    View in: PubMed
  407. Keshavan M, Toone BK, Marshall W, el Shazly M, Padi M. Neuroendocrine dysfunction in schizophrenia: a familial perspective. Psychiatry Res. 1988 Mar; 23(3):345-8.
    View in: PubMed
  408. Yeragani VK, Patel H, Keshavan MS. Effectiveness of desipramine in the treatment of dyshidrosis. J Clin Psychopharmacol. 1988 Feb; 8(1):76-7.
    View in: PubMed
  409. Keshavan M, Jones DA, Dube S, Grabowski J, Bell J, Sitaram N. Cardioacceleratory responses to arecoline infusion during sleep in depressive, anxious, and normal subjects. Biol Psychiatry. 1987 Dec; 22(12):1473-7.
    View in: PubMed
  410. Keshavan MS, Lishman WA, Hughes JT. Psychiatric presentation of Creutzfeldt-Jakob disease. A case report. Br J Psychiatry. 1987 Aug; 151:260-3.
    View in: PubMed
  411. Yeragani VK, Pohl R, Keshavan MS, Gershon S. Are tricyclic antidepressants effective for aphthous ulcers? J Clin Psychiatry. 1987 Jun; 48(6):256.
    View in: PubMed
  412. Keshavan MS, Yeragani VK. Primitive reflexes in psychiatry. Lancet. 1987 May 30; 1(8544):1264.
    View in: PubMed
  413. Patel HC, Keshavan MS, Martin S. A case of Charles Bonnet syndrome with musical hallucinations. Can J Psychiatry. 1987 May; 32(4):303-4.
    View in: PubMed
  414. Keshavan MS. Clonidine in benzodiazepine withdrawal. Am J Psychiatry. 1987 Apr; 144(4):530.
    View in: PubMed
  415. Patel H, Keshavan MS, Pitts KE. Adverse lung reactions to nomifensine: a posthumous note. Clin Neuropharmacol. 1987 Apr; 10(2):190-1.
    View in: PubMed
  416. Jones D, Gershon S, Sitaram N, Keshavan M. Sleep and depression. Psychopathology. 1987; 20 Suppl 1:20-31.
    View in: PubMed
  417. Sitaram N, Dube S, Keshavan M, Davies A, Reynal P. The association of supersensitive cholinergic REM-induction and affective illness within pedigrees. J Psychiatr Res. 1987; 21(4):487-97.
    View in: PubMed
  418. Narayanan HS, Keshavan MS, Padi MH. Dream interpretation in group psychotherapy: an Indian experience. Int J Group Psychother. 1986 Oct; 36(4):587-93.
    View in: PubMed
  419. Chambers J, Yeragani VK, Keshavan MS. Phobias in India and the United Kingdom. A trans-cultural study. Acta Psychiatr Scand. 1986 Oct; 74(4):388-91.
    View in: PubMed
  420. el Sobky A, el Shazly M, Darwish AK, Davies T, Griffin K, Keshavan MS. Hydergine effect on prolactin and reaction time in dementia. Biol Psychiatry. 1986 Oct; 21(12):1229-30.
    View in: PubMed
  421. Grover D, Yeragani VK, Keshavan MS. Improvement of phencyclidine-associated psychosis with ECT. J Clin Psychiatry. 1986 Sep; 47(9):477-8.
    View in: PubMed
  422. Langer G, Koinig G, Hatzinger R, Schönbeck G, Resch F, Aschauer H, Keshavan MS, Sieghart W. Response of thyrotropin to thyrotropin-releasing hormone as predictor of treatment outcome. Prediction of recovery and relapse in treatment with antidepressants and neuroleptics. Arch Gen Psychiatry. 1986 Sep; 43(9):861-8.
    View in: PubMed
  423. Keshavan MS, Yeragani VK, Chambers J. Phobic neuroses in India: a cross-cultural comparison. Br J Psychiatry. 1986 Mar; 148:341-2.
    View in: PubMed
  424. Keshavan MS, David AS, Narayanen HS, Satish P. "On-off" phenomena and manic-depressive mood shifts: case report. J Clin Psychiatry. 1986 Feb; 47(2):93-4.
    View in: PubMed
  425. Keshavan MS, Burton S, Murphy M, Checkley SA, Crammer JL. Benzhexol withdrawal and cholinergic mechanisms in depression. Br J Psychiatry. 1985 Nov; 147:560-4.
    View in: PubMed
  426. Keshavan MS, Crammer JL. Clonidine in benzodiazepine withdrawal. Lancet. 1985 Jun 8; 1(8441):1325-6.
    View in: PubMed
  427. Rao SL, Gangadhar BN, Keshavan MS, Hegde AS, Nardev G. Reaction time deficits in post traumatic syndrome. Indian J Psychiatry. 1985 Jan; 27(1):63-5.
    View in: PubMed
  428. Langer G, Resch F, Aschauer H, Keshavan MS, Koinig G, Schönbeck G, Dittrich R. TSH-response patterns to TRH stimulation may indicate therapeutic mechanisms of antidepressant and neuroleptic drugs. Neuropsychobiology. 1984; 11(4):213-8.
    View in: PubMed
  429. Keshavan MS, Narashimha Rao IV, Narayanan HS. Rate of blinking may predict neuroleptic-induced parkinsonism. Br J Psychiatry. 1983 Apr; 142:423.
    View in: PubMed
  430. Gangadhar BN, Keshavan MS, Goswami U, Rao TV. Cortical venous thrombosis presenting as catatonia: a clinicopathologic report. J Clin Psychiatry. 1983 Mar; 44(3):109-10.
    View in: PubMed
  431. Keshavan MS, Goswamy U. Tardive dyskinesia less severe in depression. Br J Psychiatry. 1983 Feb; 142:207-8.
    View in: PubMed
  432. Keshavan MS, Narayanan HS. Parental estimation of developmental level. Am J Dis Child. 1983 Jan; 137(1):87-8.
    View in: PubMed
  433. Keshavan MS. Epidemic psychoses, or epidemic koro? Br J Psychiatry. 1983 Jan; 142:100-1.
    View in: PubMed
  434. Murali T, Rao IV, Keshavan MS, Narayanan HS. Thiamine refractory-wernicke-korsakoffs syndrome - a case report. Indian J Psychiatry. 1983 Jan; 25(1):80-1.
    View in: PubMed
  435. Gangadhar BN, Chatterjee S, Appayya P, Keshavan MS, Narayanan HS. A case of de clerambault's syndrome with capgras phenomenon. Indian J Psychiatry. 1981 Oct; 23(4):373-4.
    View in: PubMed
  436. Keshavan MS, Gangadhar BN, Gautam RU, Ajit VB, Kapur RL. Convulsive threshold in humans and rats and magnetic field changes: observations during total solar eclipse. Neurosci Lett. 1981 Mar 10; 22(2):205-8.
    View in: PubMed
  437. Keshavan MS, Channabasavanna SM, Reddy GN. Post-traumatic psychiatric disturbances: patterns and predictors of outcome. Br J Psychiatry. 1981 Feb; 138:157-60.
    View in: PubMed
  438. Gangadhar BN, John CJ, Chattergi S, Keshavan MS, Narayanan HS. Rabbit syndrome: patchy disapperance in stage 1 nrem sleep. Indian J Psychiatry. 1981 Jan; 23(1):98-100.
    View in: PubMed
  439. Sampath G, Kumar YV, Channabasavanna SM, Keshavan MS. Alcoholic hallucinosis and paranoid schizophrenia-a comparative (clinical and follow up) study. Indian J Psychiatry. 1980 Oct; 22(4):338-42.
    View in: PubMed
  440. Keshavan MS, Isaac M, Kapur RL. I11-defined somatic symptoms in a South Indian rural clinic. Some preliminary clinical observations. Trop Geogr Med. 1980 Jun; 32(2):163-8.
    View in: PubMed
  441. Narayanan HS, Keshavan MS, Ramakrishna M. Changing psychiatric manifestations of neurosyphilis over a period of 23 years. Indian J Psychiatry. 1980 Jan; 22(1):94-6.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Keshavan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
See all (677) concept(s)
_
Co-Authors
See all (30) people
_
Similar People
See all (60) people
_
Same Department
Search Department
Physical Neighbors
_